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Background: Integrated care models are evidence-based approaches that advocate for 
identifying and simultaneously treating mental illness and problematic substance use. However, 
in psychiatric settings, current literature suggests that mental illnesses are often recognized and 
managed, whereas problematic substance and/or alcohol use may not always be addressed, often 
requiring care elsewhere. This pattern of care is concerning as individuals with concurrent 
conditions report higher rates of unmet care needs. Little research has examined the factors 
which allow for better detection and treatment of substance use for patients with concurrent 
mental illness and problematic substance and/or alcohol use.  
 
Objective: This thesis aims to explore the receipt of addiction care for patients with identified 
substance use within inpatient psychiatry. In particular this thesis will (i) examine the proportion 
of patients with first time admission to inpatient psychiatry who used substance and/or alcohol, 
(ii) identify the characteristics of patients admitted for an addiction and, (iii) identify the factors 
associated with receipt addiction care within acute psychiatry. 
 
Methods: This study utilized data from the Ontario Mental Health Reporting System (OMHRS) 
which is based on the Resident Assessment Instrument for Mental Health (RAI-MH). The analytic 
sample included 21946 inpatients with identified substance and/or alcohol use, admitted between 
2006 and 2018. Prevalence and demographic characteristics of those with substance and/or alcohol 
use were established. The variables significantly associated with the addiction reason for 
admission were identified. Independent variables were separated into blocks and modelled 
independently by the dependent variable, receipt of addiction care. The variables from independent 
block models were used in multivariable logistic regression analyses that were developed to 
examine factors associated with addiction care receipt during an acute episode of care in inpatient 
psychiatry.  
 
Results: Of the 21946 individuals with current problematic substance and/or alcohol use, 46.4% 
were admitted for addiction and 48.4% received addiction care during their acute stay. The 
majority of patients admitted for addiction were 25 to 44 years old, male, had completed greater 
than high school, were unemployed and, were never married. The multivariable logistic 
regression model identified several variables associated with receiving addiction care in acute 
psychiatry. Having a pre-existing substance use disorder, a CAGE score of 1+, addiction reason 
for admission and, displaying withdrawal symptoms increased the odds of addiction care receipt. 
Alternatively, patients that were involuntarily admitted to inpatient psychiatry or those at risk of 
self-harm (identified though SoS scale) had decreased odds of receiving addiction care. 
 
Conclusions: While half of all of those admitted for the first time to inpatient psychiatry had 
problematic substance use, only a quarter received addiction care. Care providers should 
consider withdrawal symptoms and the CAGE questionnaire to identify patients with an 
addiction treatment need. Indicators of severe mental illness and self-harm reduced the odds of 
receiving addiction care. There is a need for integrated addiction care that can support patients 
who use substances and have severe conditions. 
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1.1 What is Mental Illness and Substance Use? 
Persons with mental illness (MI) experience a range of conditions that may cause 
significant behavioural or psychological dysfunction (1,2). Within Canada, approximately 1 in 5 
persons live with some form of MI in their lifetime (1,2). Socially and economically, MI is a 
contributor to disability resulting in 1.5 to 7 times larger disease burden than cancer and 
infectious disease, respectively (3–5). The cost of disability and leave of absence from work 
associated with MI is double the cost of physical illness (PI) (4–7). The signs and symptoms of 
MI can vary dramatically, from feelings of sadness and hopelessness to hallucinations and 
delusions, resulting in a dynamic range of illnesses. Variety of factors influence the risk of MI 
incidence including social isolation, childhood trauma, genetic predispositions and substance 
and/or alcohol use (8,9).  
Substance use (SU) is associated with impairments in life through reoccurring and 
problematic use of alcohol or drug(s) (licit or illicit) (3–5,10). Problematic use can be considered 
as reoccurring use, use of multiple types of substances, feelings of guilt, concerns brought up by 
others and, dependence (3,5,10). The impairments to persons that use substances and/or alcohol 
include physical health problems, social dysfunction and disability. Moreover, persons that use 
substances and/or alcohol find it challenging to initiate addictions services as a result of their 
impairments, social and legal repercussions of using drugs, non-readiness for change and/or 
availability of services (3–5,10,11). This lack of treatment seeking, trepidation of repercussions 
and, overall impairment can be reflected in the number of SU related deaths. The World Health 
Organization stated in 2016, that the death rate due to alcohol and various drugs were 160235 
and 145565, respectively (4,5,12). In 2002, it was estimated that the cost of SU in Canada was 
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almost $40 billion, an aggregate including direct health care and treatment, law enforcement, 
research, and indirect productivity loss (13). 
 
1.2 Relationships between Mental Illness and Substance Use 
The concurrence of MI and SU is a complex condition as the occurrence of one often 
influences the incidence of the other (9,14–16). In 2016, it was estimated that globally 1 billion 
people would experience a MI and/or SU problem in their lifetime (17). The relationship can be 
described by the addiction vulnerability hypothesis, which states that the predispositions to SU is 
related to genetic, neurobiological and environmental factors (9,14–16). In the comorbidity of 
MI and SU, some of the aforementioned predisposing factors are combined and prime an 
individual towards the relationship between the two illnesses (9,10,14,16). Interestingly, MI can 
be considered a predisposition to using substances and/or alcohol as it increases potential for 
positive reinforcement due to the effects of substances and/or self-medication (9,10,14–16). For 
example, an individual with a cannabis addiction can possibly increase their susceptibility to 
mood disorders or psychosis based on the frequency of use and the neurological effects of 
cannabis on the brain (9,18). Alternatively, an individual might self-medicate their anxiety and 
depressive symptoms through the use of substances, particularly cannabis (9,10,19).  
Individuals are five times more likely to have a mood disorder or SUD (substance use 
disorder) when the other disorder is present (10,19–21). Additionally, some estimate that 30% of 
individuals with MI use substances and/or alcohol; further, 53% of individuals who use drugs 
and 37% of individuals who abuse alcohol may also have a MI (22–24). A national Danish study 
of psychiatric patients found the lifetime prevalence of SU was: 37% for schizophrenia, 25% for 
both depression and anxiety (25). Furthermore, the symptom severity, disability and self-harm 
behaviors increase when experiencing a comorbid MI and SUD in comparison to a single 
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disorder (19,26,27). The occurrence of MI and SU also increases the likelihood of a physical 
illnesses (PI), usually as a chronic condition (28–30). In Canada, it was estimated that 29% of 
individuals with a comorbid MI and SUD had two or more chronic physical conditions (28).  
1.2.1 Perceived Self-Medication 
Understanding perceived self-medication can assist in elucidating the reasons for the 
comorbid nature of MI and SU (10,31–33). Persons who use substances may experience 
compulsions to do so in order to modulate and stabilize psychological pain (19,31–33). 
Although, there is debate on the correctness of the self-medication hypothesis as not all use of 
substances is for self-medication. For instance, persons might choose to use a substance to seek a 
short-term reward (9,31). Instead, perceived self-medication can be one of many aspects to 
understanding an individual’s use of substances and/or alcohol.  
Perceived self-medication has a cyclical nature, meaning the use of substances amounts 
to worsened or prolonged psychological symptoms which result in the re-use of substances to 
cope (19,31–33). The purpose of understanding perceived self-medication is to support 
recognition of the motivators for reliance on substances to cope with psychological distress (31–
33). It is important to note that the perceived self-medication is complementary to genetic 
perspectives of SU and are applied in conjunction when aiming to understand a persons’ 
experiences with use of substances and/or alcohol. Moreover, by applying a perceived self-
medication lens allows for a wider definition in capturing individuals who might not be 
diagnosed but are still relying on substances and/or alcohol to cope with their MI (31–33). 
1.2.2 Concurrent Disorder and Concurrent Conditions 
The clinical term used to define the occurrence of both a diagnosed MI and SUD is 
concurrent disorder (CD). Based on a 2012 survey, the prevalence of CD within Canada was 
1.2%; where CD included one diagnosed mood, anxiety or bipolar disorder occurring with a 
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diagnosed alcohol or cannabis use disorder (28). Likewise, the prevalence of CD for psychiatric 
inpatients between 2010-2011 was approximately 30% (including patients with mood/anxiety 
disorders or psychotic disorders and SUD) (34). Individuals are four times more likely to be 
admitted to inpatient psychiatry when they have CD than a MI alone (34). This increases to 20 
times the likelihood for admission to inpatient psychiatry for persons having CD than SUD alone 
(34). However, this narrow criteria for CD likely underrepresents the overall prevalence as only 
select MI and SU diagnoses are included. The prevalence of CD within Canada may 
underestimate individuals who do not have a formal diagnosis of a MI or SUD but might display 
the clinical characteristics.  
1.2.3 Specific Concurrent Relationships 
The patterns of CD may vary depending on the types of substances used and the nature of 
MI under investigation. Use of cannabis is commonly associated with mental health conditions 
such as strong associations with schizophrenia and other psychotic disorders (9,35,36). Lifetime 
use of cannabis was estimated to be 66% among individuals with psychosis (36). Some evidence 
infers a casual association between cannabis use and psychosis, suggesting that individuals who 
are predisposed to psychosis and consume cannabis are at an increased risk of developing the 
disorder with earlier incidence (9,36–38). However, some research has argued of a causal 
relationship regardless of any predisposition to psychosis (9,38). Furthermore, the psychoactive 
component of cannabis, THC, has a dose-response relationship to psychosis; in that regular users 
and heavy user are two and four times more to likely develop some form of psychosis, 
respectively (9,39). Concurrent conditions involving alcohol and depression are common, with 
estimates of about 80% of those with an alcohol use disorder (AUD: a specific type of SUD) also 
experiencing a mood disorder (40). Some research argues a casual association where alcohol 
increases the risk of depression, whereas other literature suggest that a depressive episode 
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predates the alcohol use following a self-medication hypothesis (20,40,41). Nevertheless, the 
concurrent relationships of both a MI and SU (one which feeds-off another in a casual or self-
medicated manner) requires treatment of the coexisting conditions simultaneously.  
 
1.3 Care Settings and Treatment 
 The mental health care continuum has a variety of settings in which patients can receive 
care for MI and SU, such as a general hospital, in- and out-patient psychiatry or addictions 
facilities. The ability and type of care provided is dependent on the nature of the service utilized. 
For instance, most general hospitals can provide acute care for severe MI or SU overdose; 
generally only treating the primary concern (7,27,28,42,43). Not all care settings are equipped or 
designed to provide comprehensive care for all concerns (11,43). Mental health facilities may be 
unable to simultaneously meet the complex requirements of patients, services could be 
unavailable when patients require them and, services are fragmented in care or rely on other 
facilities to respond to the needs they are unable to meet (11,28,43). Upwards of 17% of patients 
with MI and SU report unmet needs from mental health services. Unmet needs in this population 
can result in poor health outcomes and increased rates of readmission (11,28,44). Although, it is 
unknown if the reported unmet needs are linked to issues due to mental health services (11,28). 
Additionally, the unmet needs could be associated to help-seeking behaviours – as population 
surveys suggest that 35-50% of individuals with MI and SU do not seek assistance from health 
services (11). Moreover, these unmet needs are service user perspectives rather than the 
measures of service itself. Instead, quality of care measures should be used to assess not just the 
efficacy of the care provided but the ability of said service to meet the needs of patients.  
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1.3.1 Determining Care Needs 
The need for care can be identified through various methods, in particular, from patient 
self-reports to clinical assessments using instruments or scales. Self-reports conducted by the 
patient are valuable in providing insight into their own case and demonstrates potential 
motivation for change (45,46). Specifically in addiction care, the patients’ readiness for change is 
vital before care can be effective in achieving the treatment goals (such as abstinence, harm 
reduction etc.) (45,46). Readiness can also be viewed through the lens of Prochaska and 
DiClemente’s stages of change (precontemplation, contemplation, preparation, 
action/maintenance, relapse prevention); depending on where the patients is can highlight how 
motivated they are to seek out and engage in treatment (47).  
When identifying patients’ substance use treatment need, assessment should encompass 
multiple dimensions such as: person’s withdrawal symptoms (i.e. autonomic hyperactivity, hand 
tremors, illusions, anxiety etc.), degree of dependency and pattern of use (i.e. how often do they 
use, prior attempt to quit, biological factors for tolerance of substances and/or alcohol etc.), 
evaluate the patients’ motivation for change and, their social, economic, psychological and 
medical context relating to substance use (45,46). The CAGE addiction scale is an example of an 
assessment which uses four items to identify if an individual has a potential problem with 
substance use. It uses items to assess the impact of substance use on a person’s circumstance, 
such as feeling the urge to use substances upon waking, guilt about substance use and, being told 
to cut down by others. By sum, a score of 1 or greater identifies a need for addiction care 
(48,49).  
Within the addiction literature, there is a gradient to substance use known as liability to 
addiction (see Figure 1 Addiction liability distribution), in which an individual has the propensity 
for addiction (i.e. from a person who uses substances to becoming dependent on the substances) 
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(50). Once the propensity reaches a certain threshold the substance use becomes a need requiring 
treatment (50). The level of severity can then be identified to determine the intensity and number 
of services required to effectively provide care (50). Various existing instruments are used to 
identify the level of severity but employ a diagnostic approach (which is ridged in what is and is 
not considered part of a diseased state and requiring care) (51,52). It is important to understand 
need for treatment along with the severity but when determining who requires care and at what 
level – a diagnostic lens should not be a main driving factor. Although, it is not known if in a 
clinical setting a diagnosis dictates receipt of care. 
 
   
Figure 1 Addiction liability distribution (50) 
 
1.3.2 Psychiatric and Substance Use Treatment 
There are various treatment methods for individuals with MI and SU; many care settings 
apply a biological and/or therapeutic approach. Biological, also known as pharmacological, 
approaches are prescription medication-based – broadly including antipsychotic (for psychotic 
disorders), antidepressant (for mood disorders) and anxiolytic (for anxiety) medications (53). 
Therapeutic approaches, apply an evidence-based approach to have patients manually overcome, 
or reduce symptoms of their disorder(s) (53). Examples of therapeutic approaches include 
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cognitive-behaviour therapy and mindfulness-based cognitive-behaviour therapy (53). These 
therapies are considered short-term as consistent practice is required. Often, biological and 
therapeutic approaches are simultaneously applied as evidence suggest reduced rates of relapse 
when a combined effort is made (53). Biological therapeutic modalities are usually not the most 
effective method for individuals using substances and/or alcohol due to risk of increased 
addictive behaviours (53). Another important component of treatment is the overall readiness, 
need and preference of an individual; these factors should be taken into consideration when a 
care plan is made (53). This provides the individual with an environment where they are 
comfortable to complete treatment. Numerous interventions can be used specifically for 
substance use, including: providing referral to specialized counselling or programs (that are 
provided by addiction counsellors or concurrent disorder specialists), 12-step programs (which 
provide a structured approach to addiction recovery) and, harm reduction approach (applied to 
manage and educate safe use of drugs for those who are not ready for abstinence).  
1.3.3 Addiction Care in Acute Psychiatry   
Within an acute psychiatric setting a patient’s lengths of stay are typically up to 30-days, 
which is a short period of time to have the opportunity to address the goals of addiction care (i.e. 
reaching abstinence, education and/or harm reduction) (54–57). In an environment where time is 
strict, comprehensive assessment to identify need and severity along with making referrals to 
addiction/concurrent care settings are crucial in providing high-quality care (54–57). In acute 
scenarios, harm reduction and education are methods to be used prior to discharge as the patients 
can utilize these strategies before meeting with the referred program (58,59). Although the nature 
of acute care is short, patients should still be receiving some form of addiction care whether it is 
in the form of harm reduction, pharmacological, educational or therapeutic intervention. Ignoring 
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or underestimating the need in order to focus on just MI is not an effective method in improving 
MI and SU.  
1.3.4 Integrated Care Model and Current Best Practice Guidelines  
An integrated care model is a recognized method to improve patients with multifaceted 
requirements by simultaneously treating their MI and SU (60–64). An important component of 
integrated care is for the coexisting illnesses to be treated in the same environment and at the 
same time (60–66). Treatment occurring in the same location reduces opportunity for drop-out 
and “falling through the cracks” (when one service relies on another to provide the treatment but 
the patient is lost as a result of follow-up, not being ready or wanting to engage in the health care 
system) (67,68). The integrated care model allows for both concerns to concurrently improve 
without having one illness cause the other to worsen and reduces the likelihood of patients not 
receiving care (60–66,69). 
The National Institute for Health and Care Excellence (NICE) based in the United 
Kingdom, has recently published best practice guidelines for treating patients with MI and SU 
(70). This guideline emphasizes identification of coexisting CD by applying thorough 
assessments and inquiring about SU activities of patients that present with MI (70). Although 
this document provides evidence for the need for identifying CD, it does not apply an integrated 
care approach. The guideline fails to address the need to treat CD in one location, focusing on 
improving MI and SU together. In a Canadian context, Health Quality Ontario has created best 
practice guidelines for specific disorders; including quality standards that recommend the 
identification and treatment of coexisting MI and SU. For instance, the document “Unhealthy 
Alcohol Use and Alcohol Use Disorder”, recommends that all concurrent health conditions 
occurring with AUD be recognized and the subsequent treatments not be delayed (71,72). The 
best practice guidelines for schizophrenia care in the community and hospital, go further to apply 
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an integrated approach, advising that clinicians offer treatment for coexisting MI and SU and, 
that health services provide resources for SU components of CD as soon as possible (73).  
 
1.4 Framing the Context in Ontario 
Ontario is the largest province by population in Canada, housing a socially diverse, 
heterogenous peoples with a multitude of factors that distinguish one MI and SU case from 
another. Individuals can receive treatment from mental health and addictions services that are 
publicly and privately funded, though care is largely supported by a universal health coverage 
system (34,74). The cost of public expenditure on mental health and addictions services for 
2013-14 was approximately $3.5 billion (representing $3.1 billion from the Ministry of Health 
and Long-Term Care and $440 million from the Ministry of Children and Youth Services) (75). 
Ontarians, 15 years and older, reported lifetime depression to be 5%, schizophrenia or bipolar 
disorder at 3% and SU concerns at 4%; although these values do not account for multimorbidity 
and CD (76). The prevalence of CD within Ontario has been estimated to be 18.5%; although 
this does not include undiagnosed conditions (24). Even though a large proportion of the 
population has MI and SU, when engaging with mental health services, Ontario residents report 
higher rates of poor accessibility and acceptability – with reports of unmet or partially met needs 
to be 46.1% higher than the national average (77). Finally, Ontario has interest in supporting 
performance measures for mental health and addiction services in order to monitor and, evaluate 
various sectors of services (78). This makes Ontario a compelling province in Canada to 
investigate addiction service provision.  
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Study Rationale and Objectives: 
2.1 Knowledge Gaps and Study Rationale 
The purpose of this study is to investigate factors associated with receipt of addiction care 
among those identified with problematic use of substance and/or alcohol within acute inpatient 
psychiatry. The rationale for this study is based off the following gaps found in the literature: 
1) The definition of CD, within a mental health context, is rigid: 
Studies have considered the relations between the coexisting conditions; however, due to 
the current diagnostic approach to classifying CD, the prevalence of those with a need are 
possibly underrepresented. This study will consider the symptomology of coexisting conditions 
within the data in an approach to be more inclusive of patients who clinically present with CD 
but have yet to be diagnosed. This method will allow for a more representative sample within 
acute psychiatry. 
2) Limited research examining the detection and addiction treatment of patients that use 
substances and/or alcohol and have MI: 
The extent to which the proportion of patients with MI and SU receive addiction care is 
unknown. Various best practice guidelines suggest applying an integrated approach to 
simultaneously treating SU and MI but, MI is often the focus of recognition and subsequent care 
receipt. It is important to identify the number of patients who engage with the mental health care 
system, are recognized with SU and receive addiction care. 
3) Factors that increase an individual’s chance of receiving addictions related treatment 
are unclear: 
There is a paucity of research that examines factors associated with the likelihood of 
receiving addiction care. Understanding whether differences in clinical and demographic 
characteristics of patients with problematic use of substances and/or alcohol increase or reduce 
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the odds of receiving addiction care can provide new insight to understanding how to improve 
and maintain care moving forward.  
4) Limited research has been conducted on patients admitted for the first time to acute 
inpatient psychiatry, with MI and problematic use of substances and/or alcohol. 
The literature currently available represents persons with MI and SU within the 
population, long-stay psychiatric facilities and other clinical settings. Patients admitted to acute 
inpatient psychiatry for first episode admission is a novel setting to investigate level of patients’ 
needs and receipt of addiction care. This environment provides a short-stay in which admission 
and discharge information, along with a multitude of demographic, clinical and treatment items 
can be utilized to investigate comprehensive assessment, identification and the start of high-
quality treatment for patients with MI and SU. Moreover, acute psychiatry is the most common 




Considering the complex requirements of patients with MI and SU and the identified 
research gaps, the current study aims to complete three research objectives:  
Objective One: What proportion of patients in acute psychiatry have problematic use of 
substances and/or alcohol? 
This objective will examine the proportion of patients admitted to acute inpatient 
psychiatry for the first time, between 2006 to 2018, who used substances and/or alcohol prior to 
admission – establishing the sample for this study. To identify problematic substance and/or 
alcohol use, the substance use clinical assessment protocol (SUBUSE CAP) embedded in the 
Resident Assessment Instrument-Mental Health (RAI-MH) will be utilized. 
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Objective Two: What characteristics are associated with being admitted to acute 
psychiatry due to addiction?   
Objective 2 will identify the characteristics of patients whose reason for admission to 
acute inpatient psychiatry is addiction. By using a population of patients with problematic 
substance and/or alcohol use, this objective can identify demographic, clinical, diagnostic and 
other characteristics that relate to the recognition of addiction care need. In doing so, potential 
variables associated with receipt of addiction services can be identified.  
Objective Three: 
a) What proportion of patients who use substances and/or alcohol receive addiction 
care? 
b) Among patients who use substances and/or alcohol, what factors are associated with 
receiving addiction care? 
Objective 3 will utilize the significant factors found to be associated with admission due 
to addiction and examine whether they are also associated with receipt addiction care within 





3.1 Study Design & Data 
This study used a cross-sectional, retrospective analysis of the first episode of care for 
persons admitted to acute psychiatry between January 1st 2006 to December 31st 2018 in Ontario, 
Canada. This study used data from the Ontario Mental Health Reporting System (OMHRS) from 
the Canadian Institute for Health Information (CIHI), which is collected from assessments using 
the Resident Assessment Instrument for Mental Health (RAI-MH). The RAI-MH data are 
submitted to CIHI, who is responsible for assessing data quality, validity and consistency along 
with data anonymization, cleaning and, storage (79). The RAI-MH, is a clinically and 
psychometrically valid assessment completed on admission to, and at discharge from, inpatient 
psychiatric facilities in Ontario, Newfoundland, and sites in Manitoba and Quebec (61-63). This 
study used data from both admission to and discharge from Ontario hospitals. 
Any member of the interdisciplinary team providing care to the patient completed the 
assessment. While not involved in the direct completion of RAI-MH, first-responders and 
patients’ families are important key informants that provide information to the care team 
completing the comprehensive assessment. Items on the RAI-MH are organized into domains 
that include personal items, referral information, mental health service history, mental status, 
substance use and excessive behaviours, cognition, self-care, health conditions and possible 
medication side effects, stressors, service utilization and treatments and, resources for discharge 
(8,45,80,81). The items capture information that provides guidance for clinical care planning, 
resource allocation and, measuring the quality of care. Within the RAI-MH are clinical tools 
such as the Clinical Assessment Protocols (referred to as CAPs) and scales such as the 
Depression Severity Index or Positive Symptom Scale, which assist health care providers in the 
care planning with patients and measuring outcomes (45). For instance, the substance use 
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(SUBUSE) CAP is a collection of items within the interRAI instrument; when these items are 
endorsed, the CAP is triggered (45).  
3.1.1 Substance Use Clinical Assessment Protocol 
The SUBUSE CAP can be triggered for two reasons: (i) the patient has current 
problematic use of substances or, (ii) the patient has prior history of substance use (45). Patients 
that trigger the SUBUSE CAP for current problematic substance use include the following: use 
of illicit substances (i.e. inhalants, crack/cocaine, opiates) in the last 90 days, consuming five or 
more alcoholic drinks in a single sitting within the last 14 days or, purposeful misuse of 
medication in the last 90 days (45). Patients that trigger the SUBUSE CAP for prior history of 
problematic substance use have not used substances within the last 90 days but have a potential 
for relapse (45). This group included the following: a history of illicit drug use but not in the last 
90 days, history of injection drug use but not in the last 30 days, have a score of 1 or more on the 
CAGE addictions screen and, are in a social environment conducive to substance use (45). 
Although the first reason for CAP trigger is more urgent as the concern is currently present, the 
second trigger should be provided with treatment as potential relapse would negatively impact 
treatment moving forward (45,46).  
 
3.2 Study Setting and Participants 
 This study includes patients admitted to acute psychiatry in Ontario, who were identified 
in the data based on: (i) admission year between January 1st 2006 to December 31st 2018, (ii) no 
record of recent (within the last two years) psychiatric admission and, (iii) age of 18 years or 
older at time of admission. Patients who are designated as acute often require urgent care for 
their symptoms, including crisis assessment and stabilization, treatment of patient’s MI and 
substance and/or alcohol needs and building their network of support within the community 
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before discharge (55,56). Patients within addictions units were excluded because receipt of 
addiction care is implicit in their program. Short-stay visits (less than 2 days) will be excluded 
from the study population, as a full assessment was not completed for this group.  
 
3.3 Ethics 
The Office of Research Ethics at the University of Waterloo provided the ethics clearance 
for this study on March 26th, 2020 under the ORE file number 41949. 
 
3.4 Variables 
The variables considered in this study are described below. 
3.4.1 Independent Variables 
The independent variables can be found within Table 1, separated into block numbers and 
data operations. Below, each block grouping is described. 
Table 1 List of independent block variables 








Length of Stay 
Contact with Community Mental Health 
Insight Into Mental Health 
Involuntary Admission 
Incapable of Consenting 




Has legal guardian/substitute decision-marker 
Addiction Reason for Admission (RFA) 
 




Hallucinogen Use  
Crack or Cocaine Use 
Stimulant Us 
Opiate Use 
Risk of Harm to Others (RHO) 
Aggressive Behaviour Scale (ABS) 
Self-Care Index (SCI) 
Severity of Self-harm (SoS) 
Activities of Daily Living (ADL) 





Intentional Misuse of Medication 
Withdrawal Symptoms 
CAGE 
Substance Use Scale 
 
Block 5 Mental Status Variables 
Depressive Severity Index (DSI) 
Cognitive Performance Scale (CPS) 
Mania Scale 
Anhedonia/Social Withdrawal 
Positive Symptom Scale 
Trauma CAP 
Anxiety Scale 
Substance Use Disorder Diagnosis 
 
Block 1 Demographic Variables: 
1. Age: Categorical variable operationalized into four groups: 18 to 24, 25 to 44, 45 to 64 
and, 65+. 
2. Gender: Categorical variable for male, female and other. Operationalized into binary: 
male and female/other. 
3. Education: Categorical variable, operationalized into less than high school or unknown, 
high school and, greater than high school. 
4. Employment: Categorical variable, operationalized to binary: currently employed and 
unemployed.  
5. Unemployment risk: A total of six binary variables (including increase in lateness and 
absenteeism over the last 6 months, poor productivity or disruptiveness at work/school, 
expresses intent to quit work/school, persistent unemployment or fluctuating work history 
over the last 2 years) are operationalized into a binary-sum variable for risk or no risk of 
unemployment.  
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6. Marital Status: Categorical variable with six levels, operationalized to three levels: never 
married, married/partner/significant other and, widowed/separated/divorced. 
7. Homelessness: Categorical variable, operationalized to binary (yes/no).  
8. Lived Alone: Categorical variable of who the patient lived with at admission which is 
operationalized to binary, lived alone or did not live alone.  
9. Residential Stability: Binary variable (yes/no) reporting if prior to admission the patient’s 
most recent residence was temporary (i.e. shelter). 
Block 2 Clinical Variables: 
Clinical variables, are administrative and medical items that provide a comprehensive 
interpretation of the patient.  
1. Reasons for Admission (RFA) was Addiction: Categorical variable used to identify 
patients’ reasons for admission (including threat or danger to self, to others, Specific 
psychiatric symptoms, forensic). This is operationalized to binary: Yes patient has a RFA 
due to addiction and no patient do not have a RFA due to addiction. It is important to 
note that the “yes” group can include other types of reasons along with addiction.   
2. Length of Stay: The length of stay was operationalized into five categorize: 0 to 2 days, 3 
to 7 days, 8 to 14 days, 15 to 30 days and 31+ days. The categorizes 0 to 2 days and 31+ 
days are used to remove any patients that have short/long stay acute visits from the 
sample. The other remining three categorize will be used in the analyses.  
3. Contact with Community Mental Health: Categorical variable operationalized to binary: 
Yes contact in the last 31 days / 30 day or less and no contact with community mental 
health.  
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4. Insight Into Mental Health: The clinical staff rate the person’s insight into their mental 
health condition as none, limited, or full. None or limited were recoded to be “No” 
insight”  while full was coded as “Yes” for insight.  
5. Involuntary Admission: Categorical variable for patient status at time of assessment with 
five categories for various patient status is operationalized to binary: Yes involuntary and 
no not involuntary.  
6. Incapable of Consenting: Binary variable (yes/no) 
7. Incompetent to disclose info related to clinical record: Binary variable (yes/no) 
8. Has legal guardian/substitute decision-marker: Binary variable (yes/no) 
Block 3 Substance Use Variables: 
Substance use status variables will be used to discern the frequency of specific substances, 
count of number of substances used in the last 90 days, withdrawal symptoms and CAGE 
addiction scale.  
1. Alcohol Use: Categorical variable operationalized to binary: Yes, more than five drinks in 
a single sitting in a 14 day period and No, less than five drinks in a single sitting in a 14 
day period.  
2. Tobacco Use: Categorical variable operationalized to binary: Yes, chews/smokes tobacco 
daily or not in the last three days but is a daily smoker and no. 
3. Inhalant Use: Categorical variable with five levels (0=Never or more than 1 year ago, 
1=Within the last year, 2=Within the last 3 months, 3=Within the last month, 4=Within 
the last 7 days, 5=Within the last 3 days) which is operationalized to binary: Yes within 
the last 90 days and not in the last 90 days. Use of 90 day cut-off period is used as the 
SUBUSE CAP is created to trigger for patients within a 90 day window.  
4. Hallucinogen Use: See number 3 above.    
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5. Crack or Cocaine Use: See number 3 above.    
6. Stimulant Use: See number 3 above.    
7. Opiate Use: See number 3 above.    
8. Cannabis Use: See number 3 above.    
9. Gambling: Binary (yes/no) 
10. Intentional Misuse of Medication: Binary (yes/no) 
11. Withdrawal Symptoms: Categorical variable with levels based on severity is 
operationalized to binary: Yes, withdrawal symptoms are present and no, withdrawal 
symptoms are not present. 
12. CAGE: This is a composed of four binary variables used to indicate potential problems 
with substance addiction without a formal diagnosis. Variables included are: felt the need 
to cutdown on substance(s), angered by criticism from others, felt guilt for using 
substance(s), used substance(s) as an “eye-opener” in the morning (45,82). The sum of 
the four variables was calculated, ranging from 0 to 4 and, dichotomized as: 1= potential 
problem with substance addiction (cut-off= 1+) and 0= No potential problem with 
substance addiction (cut-off= 0).  
13. Substance Use Scale: A variable that sums the number of substances used within the last 
90 days (inhalants, hallucinogens, crack/cocaine, stimulants, opiates, cannabis), 
medication misuse, tobacco use and problematic use of alcohol. The categorical variable 
has three levels: 0= no substances used, 1= 1 to 2 substances used and, 3= 3 or more 
substances used.  
Block 4 Behaviour & Risk Variables: 
Behaviour and risk variables provide an understanding of the patients ability to take care 
of themselves and, their risk to harming themselves and others.  
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1. Risk of Harm to Others (RHO): This variable reflects the patients’ risk of harm to others, 
with a higher score indicating increased risk (45). Operationalized to binary: Yes (score 
of 1 or more) and No (score of zero).   
2. Aggressive Behaviour Scale (ABS): Is a measure of frequency and type of aggressive 
behaviour. Includes items for verbal abuse, physical abuse, socially 
inappropriate/disruptive, resists care (83). Operationalized to binary: Yes (score of 1 or 
more) and No (score of zero).   
3. Self-Care Index (SCI): Identifies patient’s ability to care for themselves due to psychiatric 
symptoms (45). Operationalized to binary: Yes (score of 1 or more) and No (score of 
zero).   
4. Severity of Self-harm (SoS): Identifies patient’s risk of harm to self and mental health 
symptoms through various items including: history of self-injury ideation, history of 
suicide attempt(s), mental health symptoms, cognitive performance, family concerns 
about the person and suicide plan (45). A higher scores indicating greater risk of self-
harm (45). Operationalized to binary: Yes (score of 1 or more) and no (score of zero).   
5. Activities of Daily Living (ADL): A measure of the patient’s ability to perform everyday 
activities. Operationalized to binary: Yes (score of 1 or more) and No (score of zero).   
6. Instrumental Activities of Daily Living (IADL): A measure that reflects the patients’ 
ability to carry out instrumental ADLs such as meal preparations and finances. 
Operationalized to binary: Yes (score of 1 or more) and No (score of zero).    
 
Block 5 Mental Status Variables: 
Mental status variables will be used within the multivariate logistic regression model, to 
assess significance of MI on the contact with addiction care. 
 22 
1. Depressive Severity Index (DSI): A measure of negative mood indicators including 
sad/pained facial expressions, negative statements, self-deprecation, guilt/shame and 
hopelessness (45). Operationalized to binary: Yes (score of 3 or more) and No (score of 2 
or less).   
2. Cognitive Performance Scale (CPS): A measure describing the patients’ cognitive status 
including daily decision making, short-term memory, ability to express oneself, and self-
performance of eating (45). Operationalized to binary: Yes (score of 3 or more) and No 
(score of 2 or less).   
3. MANIA Scale: A measure of mania symptoms which includes items for hyperarousal, 
irritability, increased sociability, inflated-self-worth, pressured speech, sleep problems 
due to hypomania and labile effect (45). Higher the score indicates higher levels of 
mania. Operationalized to binary: Yes (score of 3 or more) and No (score of 2 or less).   
4. Anhedonia: Measure that reflects anhedonia symptoms. Operationalized to binary: Yes 
(score of 1 or more) and No (score of zero).   
5. Positive Symptom Scale: A measure of positive symptoms including hallucinations, 
command hallucinations, delusions and abnormal thought processes (45). Operationalized 
to binary: Yes (score of 3 or more) and No (score of 2 or less).  
6. Trauma CAP: Categorical: Type 1 = immediate safety concerns; Type 2 = Reduce impact 
of prior traumatic life events (45). Operationalized to binary: Yes (type 1 and type 2) and 
Not triggered. 
7. Anxiety Scale: A measure of the patients’ anxiety, including variables such as anxious 
complaints, fears/phobias, obsessive thoughts, compulsive behaviour, intrusive 
thoughts/flashbacks, and episodes of panic. Operationalized to binary: Yes (exhibited in 
the last 3 days) and No (not exhibited in the last 3 days).  
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8. Substance Use Disorder Diagnosis: Presence a DSM-5 substance related/addictive 
disorder diagnosis. 
3.4.2 Dependent Variables 
Addiction Counsellor Variable: 
The variable receipt of formal care in the form of an addiction counsellor, is one of two 
variables used to create the dependent variable. Within the RAI-MH assessment, an addiction 
counsellor is designated as any health care provider with training related to treatment of 
substance use and addiction. Therefore, contact by an addiction counsellor provides an indicator 
that patient’s needs for substance use care have been identified. The item is a categorical variable 
coded 0-7, representing the number of days where at least 15 minutes of care was provided 
(since the last 7 days or since admission). For this study, the item was re-coded to a binary 
variable; 0=No an addiction counsellor was not in contact and, 1=Yes an addiction counsellor 
was in contact (L1g: 1-7). This will be completed for both admission and discharge assessment 
and then combined together to form one addiction counsellor variable. 
Focus of Intervention Alcohol/Drug Related Variable:  
The focus of intervention variable is utilized alongside the addiction counsellor variable. 
This variable identified what the major focus of the intervention is; in this case, the item 
alcohol/drug treatment/smoking cessation (L4e). The variable will assist in ascertaining if 
patients are in contact with some form of addictions care/support through a health care provider 
not designated as an addiction counsellor. Focus of intervention for alcohol/drug 
treatment/smoking cessation is categorical with levels 0-3, representing: 0=no intervention of 
this type, 1=offered but refused, 2=received in the last 7 days and, 3=not received but scheduled 
to start within the next 7 days. Within this study, this variable is operationalized to binary to 
assess if focus of intervention is addictions related. Thus, the dichotomization is 0= focus not 
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addictions related (L4e: 0,1 and 3) and, 1= focus is addictions related (L4e: 2 only). 
Operationalization is completed for both admission and discharge, then combined together, 
similar to the addiction counsellor variable.  
Addiction Care Variable: 
 This variable is a combination of the two new operationalized variables, formal care from 
an addiction counsellor and focus of intervention alcohol/drug treatment/smoking cessation. 
Addiction care includes care given at admission and discharge. The variable is coded as binary; 
Yes= addiction care was given or No= addiction care was not given. Addiction care will function 
as the dependent variable for objective 3b. 
 
3.5 Analysis 
This study used Statistical Analysis Software (SAS) version 9.4. 
3.5.1 Analysis Sample Size 
The study sample obtained from OHMRS 2019, assembled using the exclusion criteria, 
will include a total of 44516 patients within acute inpatient psychiatry.  
3.5.2 Statistical Analysis  
Objective One Analysis: 
To identify the proportion of patients who use substances and/or alcohol, recognized 
through triggering of the SUBUSE CAP, PROC FREQ function was used. Moreover, the 
frequency of patients admitted for addiction and the proportion that received addiction care were 
also identified. Patients that did not trigger the SUBUSE CAP were removed from the sample. 
Patients that triggered the SUBUSE CAP were identified with current or prior problematic 
substance use behaviours, thus this study can apply the assumption that all patients should be 
receiving addiction care. After the sample size is reduced, bivariate statistics through frequency 
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tables are completed between RFA by SUBUSE CAP and addiction care receipt to highlight the 
potential importance of RFA for addiction. Additionally, the relationship between SUBUSE 
CAP and addiction care was examined using a chi-square analysis. Finally, univariate population 
statistics for this reduced sample are identified using block 1 to 5.  
Objective Two Analysis: 
The descriptive statistics and characteristic of the population are highlighted through 
cross-tabulation between all variables from block 1 to 5 and RFA for addiction variable. 
Frequency table function is utilized with chi-square procedure (PROC FREQ CHISQ) to 
determine any association between potential covariate. The variables with a p-value greater than 
or equal to alpha of 0.05 will be considered as covariates and will not be used further. The 
statistically significant variables will be applied to model creation in objective 3b.  
Objective Three A Analysis:  
Bivariate statistics are calculated to determine the proportion of patients who use 
substances and/or alcohol that received addiction care are identified through cross-tabulation. 
This is completed to reveal the population in the study and their frequency of addiction care 
receipt.  
Objective Three B Analysis:  
Preliminary multivariate logistic regression models were developed for identifying block 
variables associated with addiction care contact using the statistically significant variables found 
in objective two. Each block was separately modelled to ascertain significance between a smaller 
set of variables and the dependent variable. Within each model, variables that are not statistically 
significant were removed. Non-significance is identified through a p-value greater than 0.05. 
Next, the statistically significant variables from the preliminary block models were 
entered into a full multivariable model 1. A manual backwards stepwise method is used to 
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remove the not statistically significant variables starting from block 5 variables and working 
towards block 1. Consideration for a final predictive model was stringent and removing variables 
are based on the following rules: (i) p-value of less than 0.01, (ii) OR greater than 1.0 with 95% 
CI not spanning 1.0, (iii) OR less than 1.0 with 95% CI not spanning 1.0 and, (iv) parsimony and 
lack of collinearity between variables. The C-statistic is used to identify goodness of fit, with a 
value of 0.70 as a minimum cut-off. Within the combined model the C-statistic will be the 
highest as all variables are included. As variables are removed, the C-statistic will decrease but 
the value will be monitored to understand that importance of that variable within the model. Age 
and gender are important variables that impact addiction care and carry potential bias when in 
psychiatry (84–86). Thus, irrespective of the statistical significance these important confounding 
variables will be retained in all models.  
Sensitivity Analysis:  
A sensitivity analysis was completed to account for the focus of intervention alcohol/drug 
treatment/smoking cessation variable. The focus of intervention variable cannot disentangle 
alcohol/drug treatment and smoking cessation. Thus, to control for the smoking cessation all 
patients that smoke or chew tobacco are removed from the sample. The final model is then 





4.1 Objective One: What proportion of patients in acute psychiatry have 
problematic use of substances and/or alcohol? 
4.1.1 Univariate Statistics for Acute Psychiatry 
From 2006 to 2018, 44516 individuals, based on the inclusion criteria mentioned above, 
utilized acute psychiatric care within Ontario, Canada. Of the patients within acute psychiatry, 
49.3% (n=21946) triggered the SUBUSE CAP. In particular, 44.8% (n=19928) triggered for 
current problematic use of substances and 4.5% (n=2018) triggered due to prior history of 
problematic substance use. The prevalence of RFA identified as problems with addiction was 
24.6% (n=10944) while the overall prevalence of patients that received some form of addictions 
care during their acute stay was 27.6% (n=12298). 
Table 2 Proportion of patients within acute psychiatry who triggered the substance use CAP, 
were admitted for addiction and those that received of addiction care 
 n % 
Total Population 44516  
Total Population that triggered SUBUSE CAP 21946 49.3 
SUBUSE CAP None 22570 50.7 
Current Use 19928 44.8 
Prior Use 2018 4.5 
Reason for Admission Yes 10944 24.6 
Addiction No 33572 75.4 
Addiction Care Yes 12298 27.6 
No 32218 72.4 
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Figure 2 Visual categorization of patients within acute psychiatry who (i) trigger the SUBUSE 
CAP, (ii) were admitted for addiction and, (iii) received addiction care 
 
4.1.2 Descriptive statistics for patients that trigger the SUBUSE CAP 
Amongst those who trigger the SUBUSE CAP (n=21946), 90.8% (n=19928) triggered 
the CAP for current problematic use of substances whereas 9.2% (n=2018) triggered the CAP 
due to prior history of problematic substance use. Of the patients that triggered the SUBUSE 
CAP for current problematic use of substances, 92.8% (n=9440) had a RFA related to addiction. 
Among patients that triggered the SUBUSE CAP for prior problematic substance use, 7.2% 
(n=731) had a RFA related to addiction. Overall, among those that trigger the SUBUSE CAP, 
48.4% received addiction care; with 92.7% (n=9854) having current problematic substance 
and/or alcohol use and 7.3% (n=771) with prior problematic substance and/or alcohol use.  
 Among those who triggered the CAP, 40.5% of patients were 25 to 44 years old, 59.2% 
were male, 52.3% had completed greater than high school, 34.4% were employed, 29.4% had 
unemployment risk, 55.5% were never married, 28.4% lived alone and, 25.3% were homeless. 
Additionally, 58.7% of patients had a length of stay between 8 to 14 days, 87.9% had insight into 
their own mental health and, 17.7% were involuntarily admitted to inpatient psychiatry. Of 
patients within acute psychiatry, 66.4% used 1 to 2 types of substances in the last 90 days. In 
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terms of type of substances used: 33.1% consumed 5 or more alcoholic drinks in a single sitting 
in the last 14 days, 53.3% chewed or smoked tobacco daily/ not in the last three days but are a 
daily smoker. In the last 90 days, 15.3% of patients used crack/cocaine, 12.0% used opiates, 
48.8% used cannabis and, 27.9% misused prescription/over-the-counter medication. Moreover, 
47.4% of patients had potential problem with substance addiction based on the CAGE and 21.0% 
had withdrawal symptoms related to substances. Sixty percent of patients had depressive 
symptoms (based on a score equal to or greater than three on the Depressive Severity Index 
(DSI)), 33.5% had symptoms of mania, 33.0% had positive symptoms (based on the PSS) and, 
47.5% had a substance use diagnosis.  
Table 3 Proportion of patients with reason for admission due to addiction and receipt of 
addiction care by type of SUBUSE CAP trigger 
 SUBUSE CAP 
Current Use, % (n) Prior Use, % (n) Total 
Reason for Admission 
Addiction 
Yes 92.8 (9440) 7.2 (731) 46.4 (10171) 
No 89.1 (10488) 10.9 (1287) 53.6 (11775) 
Addiction Care Yes 92.7 (9854) 7.3 (771) 48.4 (10625) 
No 89.0 (10074) 11.0 (1247) 51.6 (11321) 
 
Table 4 Demographic and clinical infromation regarding the patients that triggered the substance 
use CAP within acute psychiarty  
Demographic and Clinical Variables n % 
Age group 18-24 5524 25.2 
25-44 8877 40.4 
45-64 6355 29.0 
65+ 1190 5.4 
Gender Male 12986 59.2 
Female/Other 8960 40.8 
Education Less than Highschool or 
Unknown 
4369 59.2 
Highschool 6107 27.8 
Greater than Highschool 11470 52.3 
Employment Unemployed 14406 65.6 
Employed 7540 34.4 
Unemployment Risk No Risk 15464 70.5 
Risk 6482 29.5 
Marital Status Never Married 12181 55.5 
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Demographic and Clinical Variables n % 






Homelessness No 16388 74.7 
Yes 5558 25.3 
Lived Alone No 15706 71.6 
Yes 6240 28.4 
Residential Stability No 15954 72.7 
Yes 5992 27.3 
Length of Stay 3-7 days 89 0.4 
8-14 days 12881 58.7 
15-30 days 8976 40.9 
Contact with Community Mental Health No 15752 71.8 
Yes 6194 28.2 
Insight Into Mental Health No 2664 12.1 
Yes 19282 87.9 
Involuntary Admission No 18069 82.3 
Yes 3877 17.7 
Incapable of Consenting No 21285 97.0 
Yes 661 3.0 
Incompetent to disclose info related to 
clinical record 
No 21613 98.5 
Yes 333 1.5 
Has legal guardian/substitute decision-
marker 
No 21310 97.1 
Yes 636 2.9 
Alcohol Use No 14683 66.9 
Yes 7263 33.1 
Tobacco Use No 10240 46.7 
Yes 11706 53.3 
Inhalant Use No 21716 99.0 
Yes 230 1.0 
Hallucinogen Use  No 21159 96.4 
Yes 787 3.6 
Crack or Cocaine Use No 18597 84.7 
Yes 3349 15.3 
Stimulant Use No 20408 93.0 
Yes 1538 7.0 
Opiate Use No 19314 88.0 
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Demographic and Clinical Variables n % 
Yes 2632 12.0 
Cannabis Use No 11234 51.2 
Yes 10712 48.8 
Gambling No 21491 97.9 
Yes 455 2.1 
Intentional Misuse of Medication No 15830 72.1 
Yes 6116 27.9 
Withdrawal Symptoms No 17336 79.0 
Yes 4610 21.0 
CAGE No potential problem with 
substance addiction 
11542 52.6 
Potential problem with 
substance addiction 
10404 47.4 
Substance Use Scale 1-2 Substances 14567 66.4 
3+ Substances 6230 28.4 
None 1149 5.2 
Risk of Harm to Other (RHO) No 13677 62.3 
Yes 8269 37.7 
Aggressive Behaviour Scale (ABS) No 18202 82.9 
Yes 3744 17.1 
Self-Care Index (SCI) No 8479 38.6 
Yes 13467 61.4 
Severity of Self-harm (SoS) No 4814 21.9 
Yes 17132 78.1 
Activities of Daily Living (ADL) No 20596 93.9 
Yes 1350 6.2 
Instrumental Activities of Daily Living 
(IADL) 
No 17204 78.4 
Yes 4742 21.6 
Depressive Severity Index (DSI) No 8594 39.2 
Yes 13352 60.8 
Cognitive Performance Scale (CPS) No 21201 96.6 
Yes 745 3.4 
MANIA Scale No 14604 65.6 
Yes 7342 33.4 
Anhedonia No 8790 40.0 
Yes 13156 60.0 
Positive Symptom Scale No 14701 67.0 
Yes 7245 33.0 
Trauma CAP No 17993 82.0 
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Demographic and Clinical Variables n % 
Yes 3953 18.0 
Substance Use Disorder Diagnosis No 11525 52.5 
Yes 10421 47.5 
 
4.2 Objective Two: What characteristics are associated with being admitted to acute 
psychiatry due to addiction?   
The following section will highlight descriptive statistics from a cross-tabulation between 
variables from block 1 to 5 and addiction RFA. If a variable is not statistically significant 
(identified through chi-square or fisher’s exact test), the p-value will be given instead of the 
percentage. 
4.2.1 Bivariate Statistics related to Reason for Admission 
Among patients with a RFA for addiction, the prevalence for SUBUSE CAP triggers are 
as follows: 86.3% (n=9440) triggered for current use of substances, 6.7% (n=731) triggered due 
to prior history of substance use and, 7.1% (n=773) did not trigger the SUBUSE CAP. For the 
patients that did not have a RFA for addiction, the prevalence for SUBUSE CAP triggers are as 
follows: 31.2% (n=10488) triggered for current use of substances, 3.8% (n=1287) triggered due 
to prior history of substance use and, 64.9% (n=21797) did not trigger the SUBUSE CAP. The 
prevalence of patients with a RFA for addiction that received addictions care is 66.6% (n=7287) 
while those that did not receive addiction care is 33.4% (n=3657). Alternatively, the prevalence 









Table 5 Proportion of patients who triggered the substance use CAP and received addiction care 
by reason for admission being addiction 
 
4.2.2 Block 1: Descriptive Variables 
The greatest number of patients admitted for addiction are between 25 to 44 years of age 
(43.3%), followed by age groups 45 to 64 (30.1%), 18 to 24 (22.2%) and, 65 and over (4.40%). 
Males have a greater percentage of admission for addiction compared to females/other (64.9%). 
Approximately, half of the inpatient population admitted for addiction had completed education 
higher than high school (50.7%), just over a quarter completed high school (27.1%) and just 
under a quarter had less than high school or unknown (22.2%). The proportion of patients that 
were unemployed is higher than that of currently employed patients (67.7% and 32.3%, 
respectively). Of patients admitted for addiction, 31.0% were at risk of unemployment. 
Additionally, unemployment risk is similar for patients not admitted for addiction (28.4%). 
Over half of the patients admitted for addiction were never married (57.3%), followed by 
those who are married or have a partner/significant other (26.6%) and, patients who are 
widowed, separated or divorced (16.1%). Within this population, the proportion of patients that 
are homeless (28.5%) is less than the proportion of patients who are not homeless (71.5%). A 
larger proportion of patients admitted for addiction did not live alone (70.0%) compared to those 
that did live alone (30.0%). A larger proportion of patients admitted for addiction did not 




 Reason for Admission Addiction 
Yes, % (n) No, % (n) 
SUBUSE CAP None 7.1 (773) 64.9 (21797) 
Current Use 86.3 (9440) 31.2 (10488) 
Prior Use 6.7 (731) 3.8 (1287) 
Addiction Care Yes 66.6 (7287) 14.9 (5011) 
No 33.4 (3657) 85.1 (28561) 
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Table 6 Demographic characteristics of patients admitted for addiction 
 
4.2.3 Block 2: Clinical Variables 
The proportion of patients admitted for addiction with a length of stay of 8 to 14 days 
(56.9%) is similar to those with a length of stay of 15 to 30 days (42.6%). The majority of 
patients admitted for addiction have insight into their own mental health (88.6%), are competent 
to disclose information related to their clinical records (98.2%) and, entered care voluntarily 
(85.2%). Variables not statistically significant were contact with community mental health 






Block 1 Descriptive Variables Reason for Admission Addiction 
Yes, % (n) No, % (n) p-value 
Age group 18-24 22.2 (2260) 27.7 (3264) <.0001 
25-44 43.3 (4405) 38.0 (4472) 
45-64 30.1 (3064) 28.0 (3291) 
65+ 4.4 (442) 6.3 (748) 
Gender Male 64.9 (6602) 54.2 (6384) <.0001 
Female/Other 35.1 (3569) 45.8 (5391) 
Education Less than Highschool or 
Unknown 
22.2 (2253) 18.0 (2116) <.0001 
Highschool 27.1 (2758) 28.4 (3349) 
Greater than Highschool 50.7 (5160) 53.6 (6310) 
Employment Unemployed 67.7 (6887) 63.9 (7519) <.0001 
Employed 32.3 (3284) 36.1 (4256) 
Unemployment 
Risk 
No Risk 69.1 (7027) 71.7 (8437)  
Risk 30.9 (3144) 28.4 (3338)  
Marital Status Never Married 57.3 (5827) 54.0 (6254) <.0001 
Married or Partner/Significant 
Other 
26.6 (2703) 29.7 (3493) 
Widowed, Separated, Divorced 16.1 (1641) 16.4 (1928) 
Homelessness No 71.5 (7269) 77.4 (9119) <.0001 
Yes 28.5 (2902) 22.6 (2656) 
Lived Alone No 70.1 (7130) 72.8 (8676) <.0001 
Yes 29.9 (3041) 27.2 (3199) 
Residential 
Stability 
No 70.4 (7158) 74.7 (8796) <.0001 
Yes 29.6 (3013) 25.3 (2976) 
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Table 7 Clinical characteristics of patients admitted for addiction 
 
4.2.4 Block 3: Substance Use Variables 
Patients admitted for addiction used various types and numbers of substances within the 
last 90 days prior to admission, 55.5% used 1 to 2 substances, 41.0% used 3 or more substances 
and, 3.5% did not use any substances. The prevalence of patients with potential problem with 
substance addiction is 70.0% based on the CAGE, for patients admitted for addiction. Signs or 
symptoms that could be related to withdrawal of substances in the last 3 days (35.0%) is less 
prevalent than no signs or symptoms of withdrawal symptoms (65.0%) in patients admitted for 
addiction.  
Among patients admitted to inpatient psychiatry for addiction, 64.5% chewed or smoked 
tobacco daily/not in the last three days but are a daily smoker. Additionally, 42.4% consumed 5 
or more alcoholic drinks in any single sitting episode in the last 14 days. Between three days to 
90 days before admission to acute psychiatry for addiction: 51.2% of patients used cannabis, 
23.3% used cocaine and/or crack, 18.8% used opiates, 10.5% used stimulants and, 5.3% used 
hallucinogens. Alternatively, between three days and 90 days before admission, 98.8% did not 
Block 2 Clinical Variables Reason for Admission Addiction 
Yes, % (n) No, % (n) p-value 
Length of Stay 3-7 days 0.5 (51) 0.3 (38) <.0001 
8-14 days 56.9 (5748) 60.3 (7097) 
15-30 days 42.6 (4336) 39.4 (4640) 
Contact with Community 
Mental Health 
No 71.2 (7238) 72.3 (8514) 0.06 
Yes 28.8 (2933) 27.7 (3261) 
Insight Into Mental Health No 11.4 (1160) 12.8 (1504) <.01 
Yes 88.6 (9011) 87.2 (10271) 
Involuntary Admission No 85.2 (8669) 79.8 (9400) <.0001 
Yes 14.8 (1502) 20.2 (2375) 
Incapable of Consenting No 97.0 (9867) 97.0 (11418) 0.85 
Yes 3.0 (304) 3.0 (357) 
Incompetent to disclose info 
related to clinical record 
No 98.2 (9991) 98.7 (11622) <.01 
Yes 1.8 (180) 1.3 (153) 
Has legal guardian/substitute 
decision-marker 
No 97.1 (9878) 97.1 (11432) 0.89 
Yes 2.9 (293) 2.9 (343) 
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consume inhalants. Moreover, 24.1% of patients misused prescription and/or over-the-counter 
medication in the last three months. Finally, of the patients admitted for addiction, majority did 
not gamble excessively or uncontrollably in the last three months (97.4%). 
Table 8 Substance use characteristics of patients admitted for addiction 
 
4.2.5 Block 4 Behaviour & Risk Variables 
 Among patients admitted for addiction, 40.4% may be at risk of harm to others (a score 
of one or more based on Risk of Harm to Others (RHO) scale). Based on a score of one or more 
Block 3 Substance Use Variables Reason for Admission Addiction 
Yes, % (n) No, % (n) p-value 
Alcohol Use No 57.6 (5862) 74.9 (8822) <.0001 
Yes 42.4 (4310) 25.1 (2953) 
Tobacco Use No 35.8 (3636) 56.1 (6604) <.0001 
Yes 64.3 (6535) 43.9 (5171) 
Inhalant Use No 98.8 (10048) 99.1 (11668) 0.03 
Yes 1.21 (123) 0.9 (107) 
Hallucinogen Use  No 95.7 (9636) 97.9 (11523) <.0001 
Yes 5.3 (535) 2.1 (252) 
Crack or Cocaine Use No 76.7 (7803) 91.7 (10794) <.0001 
Yes 23.3 (2368) 8.3 (981) 
Stimulant Use No 89.5 (9100) 96.0 (11308) <.0001 
Yes 10.5 (1071) 4.0 (467) 
Opiate Use No 81.2 (8261) 93.9 (11053) <.0001 
Yes 18.8 (1910) 6.1 (722) 
Cannabis Use No 48.8 (4966) 53.2 (6268) <.0001 
Yes 51.2 (5205) 46.8 (5507) 
Gambling No 97.4 (9907) 98.4 (11584) <.0001 
Yes 2.6 (264) 1.6 (191) 
Intentional Misuse of 
Medication 
No 75.9 (7721) 68.9 (8109) <.0001 
Yes 24.1 (2450) 31.1 (3666) 
Withdrawal Symptoms No 65.0 (6612) 91.1 (10724) <.0001 
Yes 35.0 (3559) 8.9 (1051) 








69.9 (7110) 28.0 (3294) 
Substance Use Scale None 3.5 (355) 6.7 (794) <.0001 
1-2 Substances 55.5 (5645) 75.8 (8922) 
3+ Substances 41.0 (4171) 17.5 (2059) 
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on the Self-Care Index (SCI), 57.0% of patients admitted for addiction may be unable to care for 
themselves due to their psychiatric symptoms. The proportion of patients admitted for addiction 
with risk of self-harm is 71.0% (based on a score of one or more on Severity of Self-harm (SoS) 
measure). For patients admitted for addiction with a score greater than or equal to one, 5.7% had 
troubles with Activities of Daily Living and 19.3% has troubles with Instrumental Activities of 
Daily Living. The variable considered not statistically significant from the cross-tabulation with 
RFA related to addiction, and thus not reported is: aggressive behaviour scale (ABS; p=0.59). 
 
Table 9 Behaviour and risk characteristics of patients admitted for addiction 
 
4.2.6 Block 5 Mental Status Variables 
The proportion of patients admitted for addiction with depressive symptoms (based on 
the DSI) is 56.4%. The prevalence of anhedonia symptoms (56.4%) is exactly the same as DSI 
for patients admitted for addiction. Patients admitted for addiction and have positive symptoms 
have a prevalence of 31.0%. The prevalence of patients that triggered the Traumatic Life Events 
CAP and are admitted for addiction is 18.8%. Among patients admitted for addiction, 70.4% 
have a current SUD. The variable considered not statistically significant from the cross-
Block 4 Behaviour & Risk Variables Reason for Admission Addiction 
Yes, % (n) No, % (n) p-value 
Risk of Harm to Others 
(RHO) 
No 59.6 (6057) 64.7 (7620) <.0001 
Yes 40.4 (4114) 35.3 (4155) 
Aggressive Behaviour 
Scale (ABS) 
No 82.8 (8421) 83.1 (9781) 0.59 
Yes 17.2 (1750) 16.9 (1994) 
Self-Care Index (SCI) No 43.0 (4374) 34.9 (4105) <.0001 
Yes 57.0 (5797) 65.1 (7670) 
Severity of Self-harm 
(SoS) 
No 29.1 (2962) 15.7 (1852) <.0001 
Yes 70.9 (7209) 84.3 (9923) 
Activities of Daily 
Living (ADL) 
No 94.3 (9592) 93.5 (11004) <.01 
Yes 5.7 (579) 6.5 (771) 
Instrumental Activities 
of Daily Living (IADL) 
No 80.7 (8209) 76.4 (8995) <.0001 
Yes 19.3 (1962) 23.6 (2780) 
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tabulation with RFA related to addiction, and thus not reported are: Cognitive performance scale 
(CPS; p=0.87), MANIA scale (p=0.58) and, anxiety scale (p=0.27). 
Table 10 Mental status characteristics of patients admitted for addiction 
 
4.3 Objective Three A: What proportion of patients who use substances and/or 
alcohol receive addiction care? 
Among the inpatients that received addiction care, 49.4% triggered the SUBUSE CAP for 
current problematic substance use and 38.2% triggered SUBUSE CAP for prior history of 
problematic substance use. Of the patients within acute psychiatry that did not receive addiction 
care, 50.6% triggered the SUBUSE CAP for current problematic substance use and 61.8% 
triggered SUBUSE CAP for prior history of problematic substance use. 
Table 11 Proportion of patients that received addiction care by the type of SUBUSE CAP trigger 
 Addiction Care 
Yes % (n) No % (n) 
SUBUSE CAP None n/a n/a 
Current Use 49.4 (9854) 50.6 (10074) 
Prior Use 38.2 (771) 61.8 (1247) 
Total 48.4 (10625) 51.6 (11321) 
Block 5 Mental Status Variables Reason for Admission Addiction 
Yes, % (n) No, % (n) p-value 
Depressive Severity Index (DSI) No 43.6 (4436) 35.3 (4158) <.0001 
Yes 56.4 (5735) 64.7 (7617) 
Cognitive Performance Scale 
(CPS) 
No 96.6 (9828) 96.6 (11373) 0.87 
Yes 3.4 (343) 3.4 (402) 
MANIA Scale No 66.4 (6749) 66.7 (7855) 0.58 
Yes 33.6 (3422) 33.3 (3920) 
Anhedonia No 44.6 (4430) 37.0 (4360) <.0001 
Yes 56.4 (5741) 63.0 (7415) 
Positive Symptom Scale No 69.0 (7023) 65.2 (7678) <.0001 
Yes 31.0 (3148) 34.8 (4097) 
Trauma CAP No 81.2 (8263) 82.6 (9730) <.01 
Yes 18.8 (1908) 17.4 (2045) 
Anxiety Scale No 98.8 (10044) 98.9 (11647) 0.27 
Yes 1.2 (127) 1.1 (128) 
Substance Use Disorder 
Diagnosis 
No 29.7 (3016) 72.3 (8509) <.0001 
Yes 70.3 (7155) 27.7 (3266) 
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4.3 Objective Three B: Among patients who use substances and/or alcohol, what 
factors are associated with receiving addiction care? 
4.3.1 Block Modeling 
Preliminary multivariate logistic regression models were developed to examine the 
relationship between the receipt of addiction care (binary dependent variable) using the 
statistically significant variables found in objective two. Each block was separately modelled to 
ascertain significance between a smaller set of variables and the dependent variable. Within each 
model, variables that were not statistically significant were removed and the associated model 
was rerun. Non-significance is identified through a p-value greater than 0.05.  
Table 12 Multivariate logistic regression block models examining the relationship between 
demographic, clinical, substance use, behaviour and risk and, mental status characteristics by 
receipt of addiction care 
Variables OR (95% CI) p-value C-statistic 
Block Model 1   0.59 
Age 25-44 1.57 (1.46-1.69) <.0001  
45-64 1.48 (1.35-1.61) <.0001  
65+ 0.89 (0.77-1.03) <.01  
Gender  0.68 (0.65-0.72) <.0001  
Education Highschool 0.88 (0.81-0.95) <.01  
> Highschool 0.81 (0.75-0.87) <.0001  
Employed  0.88 (0.83-0.93) <.0001  
Unemployment Risk  1.13 (1.07-1.20) <.0001  
Marital Status Married or 
Partner/Significant 
Other 




1.01 (0.93-1.11) 0.73  
Homelessness  1.14 (1.07-1.21) <.0001  
Lived Alone   1.06 (0.99-1.13) 0.09  
Residential Stability  1.05 (0.99-1.12) 0.10  
Block Model 2   0.72 
Length of Stay 8-14 days 0.96 (0.61-1.52) 0.87  
15-30 days 1.09 (0.69-1.72) 0.71  
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Variables OR (95% CI) p-value C-statistic 
Insight into own Mental 
Health 
 1.43 (1.31-1.57) <.0001  
Involuntary Admission  0.62 (0.50-0.82) <.0001  
Incompetent to disclose 
information related to 
clinical records 
 0.64 (0.50-0.82) <.01  
Reason for Admission 
Addiction 
 5.23 (4.93-5.54) <.0001  
Block Model 3a   0.78 
Alcohol Use  1.47 (1.38-1.59) <.0001  
Tobacco Use  1.87 (1.77-1.99) <.0001  
Inhalant Use  0.64 (0.47-0.87) <.01  
Hallucinogen Use  0.84 (0.71-1.01) 0.06  
Crack/Cocaine Use  1.74 (1.59-1.91) <.0001  
Stimulant Use  1.39 (1.22-1.58) <.0001  
Opiate Use   2.12 (1.91-2.36) <.0001  
Cannabis Use  1.06 (1.00-1.13) 0.07  
Gambling  0.89 (0.72-1.10) 0.26  
Medication Misuse  0.79 (0.73-0.85) <.0001  
Withdrawal Symptoms  2.67 (2.46-2.91) <.0001  
CAGE  3.09 (2.90-3.29) <.0001  
Block Model 3b   0.62 
Substance Use Scale No Substances 0.65 (0.57-0.74) <.0001  
3+ Substances 3.09 (2.90-3.29) <.0001  
Block Model 4   0.59 
Harm to Others (RHO)  1.29 (1.22-1.36) <.0001  
Self-Care Index (SCI)  0.75 (0.71-0.80) <.0001  
Severity of Self-harm (SoS)  0.48 (0.45-0.51) <.0001  
ADL Scale  1.02 (0.90-1.15) 0.78  
IADL Scale  0.82 (0.77-0.88) <.0001  
Block Model 5  
 0.73 
Depressive Symptom Index 
(DSI) 
 0.98 (0.92-1.04) 0.49  
Anhedonia  0.90 (0.85-0.96) <.01  
Positive Symptom Scale 
(PSS) 
 0.85 (0.80-0.91) <.0001  
Trauma CAP  1.18 (1.09-1.28) <.0001  
Substance Use Disorder 
Diagnosis   




4.3.2 Combined Modeling 
Combined Model 1:  
Entering all variables into one model resulted in a C-statistic of 0.820. The goal was to 
maintain a strong C-statistic close to 0.800 while achieving a parsimonious model for receipt of 
addictions care. In evaluating combined model 1, only block 5 variables were assessed. Positive 
Symptom Scale (p=0.38) and the Trauma CAP (p=0.07 ceased to be significant and were 
removed from the model. Substance use disorder diagnosis (p=<.0001) remained significant and 
continued in the model going forward.  
Combined Model 2:  
After rerunning the model, the C-statistic remained 0.82 (df=29). This model evaluated 
block 4, while reassessing block 5 for continued significance. Variables RHO (p=0.85), IADL 
scale (p=0.03) and SCI [OR= 0.87, 95% CI (0.81-0.93)] were not statistically significant and 
were removed, while SoS (p=<.0001) remained. 
Combined Model 3: 
The C-statistic was 0.819 (df=26). This model evaluated block 3, while reassessing block 
4 and 5. Substance type variables (df=7; including use of alcohol, crack/cocaine, inhalants, 
stimulants, opiates, tobacco and, medication misuse) were significant. However, there was 
potential collinearity between these variables and the substance use scale variable. The substance 
use scale variable identified the number of substances a patients used within the last 90 days. 
Within the predictive model context, using one variable instead of six to predict odds of 
addiction care receipt will create a more parsimonious model. To check for collinearity: the 
substance type variables are removed and the substance use scale variable becomes significant 
[p=<.0001; 3+ substances used OR= 1.52, 95% CI (1.41-1.64) & zero substances used OR= 
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0.59, 95% CI (0.51-0.69)] – therefore this one variable will remain while the other seven are 
removed. 
Combined Model 4: 
The C-statistic decreased from 0.819 (df=26) to 0.814 (df=19) for this combined model. 
Block 2 was evaluated, while reassessing blocks 3 to 5. The variable for patients competence to 
disclose information related to clinical records [OR= 0.71, 95% CI (0.55-0.93)] was removed 
from the model. 
Combined Model 5: 
The C-statistic after rerunning was 0.814 (df=18). This model evaluated block 1, while 
reassessing the continued significance of blocks 2-5. Variables such as education (p=0.52 & 
0.31), employment (p=0.18), unemployment risk (p=0.19) and, homelessness [OR= 0.89, 95% 
CI (0.82-0.95)] were not statistically significant and were removed. All variables included within 
each combined model during the model forming process can be found in Table 14. The OR/95% 
CI and p-values can be found in Appendix B. 













Block 1       
Age 25-44 X X X X X X 
45-64 X X X X X X 
65+ X X X X X X 
Gender X X X X X X 
Education Highschool X X X X X  
> Highschool X X X X X  
Employment X X X X X  
Unemployment Risk X X X X X  
Homelessness X X X X X  
Block 2       
Insight into own Mental Health X X X X X X 














Incompetent to disclose 
information related to clinical 
records 
X X X X   
Reason for Admission Addiction X X X X X X 
Block 3       
Alcohol Use X X X    
Tobacco Use X X X    
Inhalant Use X X X    
Crack/Cocaine Use X X X    
Stimulant Use X X X    
Opiate Use  X X X    
Medication Misuse X X X    
Withdrawal Symptoms X X X X X X 
CAGE X X X X X X 
Substance Use 
Scale 
No Substances X X X X X X 
3+ Substances X X X X X X 
Block 4       
Harm to Others (RHO) X X     
Self-Care Index (SCI) X X     
Severity of Self-harm (SoS) X X X X X X 
IADL Scale X X     
Block 5       
Positive Symptom Scale (PSS) X      
Trauma CAP X      
Substance Use Disorder Diagnosis X X X X X X 
       
C-statistic 0.82 0.82 0.819 0.814 0.814 0.813 
*X = Variable is included in the current model 
**Coloured cell = Variable is non-significant and will be removed from subsequent models 
 
4.3.3 Final Model 
 The final logistic regression model for predicting the receipt of addiction care contains 
the following variables: age, gender, involuntary admission, addiction RFA, insight into own 
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mental health, withdrawal symptoms, CAGE screen, substance use scale and, substance use 
disorder diagnosis The model fit is considered good with a C-statistic of 0.813 (df=13). 
In reference to patients 18 to 24 years old, the odds that a patient in acute psychiatry will 
receive addictions care is 21.3% greater for 25 to 44 years old, 11.3% greater for 45 to 64 years 
old and, 13.8% lower for 65 years and older. Females/other have a lower odds of receiving 
addiction care than males by 12.7%. Patients that are involuntarily within acute psychiatry have 
34.1% lower odds of receiving addiction care compared to patients that are voluntarily using 
acute psychiatric services. Patients with insight into their own mental health have a 31.7% 
increase in their odds of receiving addiction care compared to patients that do not have insight 
into their own mental health. The odds of addiction care given to patients increases 2.12 times 
among those with a RFA for addiction, 2.00 times for patients with signs and symptoms of 
withdrawal of substances and 2.22 times for patients with a score of one or greater based on the 
CAGE addiction screen. The odds of receiving addiction care reduces by 31.4% for those with a 
SoS score of 1 or greater compared to those who have a score of zero. In reference to using 1 to 2 
substances, patients using 3 or more substances within the last 90 days have a 52.8% increased 
odds of receiving addiction care. Moreover, patients that did not use substances within the last 90 
days have a 41.3% decreased odds of receiving addiction care. Patients with substance use 
disorder are 2.97 times more likely to receive addiction care compared to those that do not have a 
substance use disorder. The logistic regression analysis can be found in Table 14 below.  
4.3.4 Sensitivity Analysis 
 After removing patients that consumed tobacco (smoking and chewing), 9400 patients 
remained from the original SUBUSE CAP population. Within the sensitivity sample, 33.9% 
(n=3182) of patients received addictions care. Of the patients remaining, 88.4% (n=8309) 
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triggered the SUBUSE CAP for current problematic use of substances and, 11.6% (n=1091) 
triggered the SUBUSE CAP due to prior history of problematic substance use.  
The final logistic regression model for predicting addiction care is applied to this sample, 
in which all variables remain statistically significant. Moreover, the C-statistic maintains a high 
degree of model-fit at 0.822 (df=13). The odds of addiction care, in reference to patients 18 to 24 
years old, is 19.0% greater for patients 25 to 44 years old, 14.3% greater for patients 45 to 44 
years old and, 14.9% lower for patients 65 and over. Females/other have a 19.8% lower odds of 
receiving addiction care compared to males. Patients that are involuntarily within acute 
psychiatry have 32.8% lower odds of receiving addiction care compared to patients voluntarily 
using acute psychiatric services. Those with insight into their own mental health have a 30.6% 
higher odds of addiction care compared to those without insight into their own mental health. 
The odds of addiction care given to patients increases 2.65 times for patients with a score of one 
or greater based on the CAGE addiction screen, 2.44 times for patients with signs and symptoms 
of withdrawal of substances and, 2.41 times among those with a RFA for addiction. Among 
patients with a with a SoS score of 1 or greater compared to those who have a score of zero, the 
odds of addiction care decreased by 30.9%. In reference to using 1 to 2 substances within the last 
90 days, patients using 3 or more substances have a 20.9% greater odds of receiving addiction 
care. Additionally, patients that did not use any substances within the last 90 days, have a 30.6% 
decrease in their odds of receiving addiction care. Finally, patients with a diagnosed substance 
use disorder are 3.38 times more likely to receive addiction care compared to those without a 





Table 14 Multivariable logistic regression model predicting addiction care for acute psychiatric 
inpatients in Ontario, Canada and for a tobacco-free sensitivity analysis sample 
Variables 
Final Model Sensitivity Analysis 
OR (95% CI)* p-value OR (95% CI)* p-value 
Block 1     
Age 25-44 1.21 (1.12-1.31) <.0001 1.19 (1.04-1.36) 0.01 
45-64 1.11 (1.02-1.21) 0.02 1.14 (0.99-1.31) 0.06 
65+ 0.86 (0.74-1.01) 0.06 0.85 (0.69-1.05) 0.13 
Gender 0.87 (0.82-0.93) <.0001 0.80 (0.72-0.89) <.0001 
Block 2     
Insight into own Mental Health 1.32 (1.20-1.45) <.0001 1.31 (1.11-1.53) <.001 
Involuntary Admission 0.66 (0.61-0.72) <.0001 0.67 (0.59-0.77) <.0001 
Reason for Admission Addiction 2.12 (1.98-2.27) <.0001 2.41 (2.15-2.69) <.0001 
Block 3 
    
Withdrawal Symptoms 1.94 (1.79-2.13) <.0001 2.44 (2.08-2.85) <.0001 
CAGE 2.22 (2.07-2.38) <.0001 2.65 (2.37-2.97) <.0001 
Substance Use Scale No Substances 0.59 (0.51-0.68) <.0001 0.69 (0.58-0.82) <.0001 
3+ Substances 1.53 (1.42-1.65) <.0001 1.21 (1.00-1.48) 0.07 
Block 4 
    
Severity of Self-harm (SoS) 0.69 (0.63-0.74) <.0001 0.69 (0.61-0.79) <.0001 
Block 5 
    
Substance Use Disorder Diagnosis 2.97 (2.77-3.18) <.0001 3.38 (3.03-3.78) <.0001 
C-statistic 0.813 0.822 




 This study addresses several knowledge gaps surrounding mental health and addictions 
care within inpatient psychiatry. By utilizing the OMHRS data, a large comprehensive dataset, 
the results of this study find: (i) about half of patients have problematic substance and/or alcohol 
use at first admission to inpatient psychiatry, (ii) although those with an addiction RFA have 
similar characteristics to those with problematic substance and/or alcohol use, addiction RFA 
does not completely represent all persons with addiction need and, (iii) those with a SUD are 
more likely to receive addiction care and, those with severe mental health concerns are less likely 
to receive addiction care. This chapter begins with an in-depth discussion of the research 
findings, then the implications of the findings for future research and policy and, concluding with 
the study limitations. 
 
5.1 Prevalence of Problematic Substance and/or Alcohol Use 
 This was the first study to estimate the prevalence of problematic substance and/or 
alcohol use at first admission to acute psychiatric hospital stays in Ontario, Canada. Furthermore, 
this study was able to identify demographics and clinical variables associated with problematic 
substance and/or alcohol use. The care setting is an essential component of this study, in that 
acute psychiatry aims to stabilize and provide emergency care to patients with MI and SU 
(54,55,87). Prior literature has determined that substance and/or alcohol use is common among 
those with MI, and vice versa (9,14–16,18). An integrated care approach is a best-practice 
guideline when considering the optimal outcomes for people with MI and SU, which involves 
treating both illnesses simultaneously within the same environment (60–63,65,66). In an acute 
psychiatric setting, an integrated care approach would provide emergency care to MI and SU 
symptoms then discharge planning to addiction/concurrent treatment locations which provide 
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continuing care (60–63,65,66). In considering the study setting and how quality care can be 
provided, it is important to identify the proportion of people with addiction need.  
This study found that the prevalence of patients within acute psychiatry that have 
identified problematic substance and/or alcohol use is almost half of the total inpatient 
population. This is a similar finding to a 2009 study conducted in Western Cape, South Africa in 
which 51% of psychiatric patients had SUD (88). The proportion found in our study is higher 
than the estimated 20% of people with MI and SU in the general population (2). The increase 
may be a result of: (i) an acute psychiatric setting cares for people with the highest severity of 
symptoms which results in the increased comorbidity of MI and SU and, (ii) the use of symptom 
indicators of problematic substance and/or alcohol use – rather than diagnostic. Previous studies, 
such as the psychiatric study from South Africa, have determined plethora of relationships 
between MI and SU based on a formal diagnosis (1,77,88). Ultimately, these studies do not 
include patients that have symptoms of SU and/or MI. The proportion of patients within this 
study may reflect a broader criteria than what has previously been reported. 
 Of the patients that have identified problematic substance and/or alcohol use from 
triggering the SUBUSE CAP, a little less than half received addiction care. The SUBUSE CAP is 
a useful tool for alerting the care team of potential addiction needs. However, given the treatment 
setting, it may be possible that addiction care is not provided as other concerns such as MI take 
precedent. For instance, we found that 78.1% of patients had indicators of self-harm behaviours 
and 61.4% were unable to care for themselves as a result of psychiatric symptoms. Although 
other concerns might take precedent, patients with problematic substance and/or alcohol use that 
do not receive treatment risk high rates of readmission as their substance and/or alcohol 
behaviour worsen and subsequently exacerbate their MI (11,28,44). Patients may also feel 
disconnected and unsupported by the healthcare system when their problematic need (whether 
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known or unknown) are not addressed (11,28). It is important to consider that not all hospitals 
have addiction counsellors or enough addiction support to meet the demands of their patients. 
This study found that the demographic factors associated with MI and SU within the 
general population are similar to the acute psychiatric population (54,88,89). This is to be 
expected as a subset of those in the general population will access hospital services when under 
severe psychiatric and/or substance related emergencies. We found that those with problematic 
substance and/or alcohol use were generally male, between 25 to 44 years old, unemployed and, 
completed less than high school (87,90). We also found that a quarter of the population was 
homeless or lived alone and, that the majority were never married (87,90). An advantage of this 
study was the availability of scales or screeners in the OMHRS data to identify SU and MI, 
rather than defining them on the presence of diagnoses. With this broader definition, this study 
found that patients with identified problematic substance and/or alcohol use also experienced 
symptoms of depression (60.8%), mania (33.5%) and/or positive symptoms related to psychosis 
(33.0%). Additionally, among those patients that triggered the SUBUSE CAP half of them used 
cannabis in the last 90 days, used 1 to 2 substances in the last 90 days, smoked tobacco daily and 
more than a quarter had 4 or more drinks of alcohol in one sitting. 
The link between depression and use of substances and/or alcohol is well documented, 
with the prevalence ranging from 30% to 54% (91,92). A study by Frank et, al. (2007) found that 
59% of patients from Maintenance Therapies for Bipolar Disorder (MTBD) protocol had history 
of substance and/or alcohol use (93). Alcohol and cannabis were the most used substances, 
although they were not used to self-medicate the mania symptoms of bipolar disorder but rather 
the depressive symptoms (93). Various other studies have found that individuals with bipolar 
disorder engage with substance and/or alcohol more readily than the general population (94–96). 
A cross-sectional study in Oslo, Norway found that those with positive symptoms and those with 
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schizophrenia had a 40% increase in their likelihood of engaging with illicit substances in 
comparison to the general public (97). Other studies found a prevalence of 30% to 60% between 
schizophrenia and substance and/or alcohol use for patients (91,98,99). As this study focused on 
identifying MI through assessments and screens, statistical associations between formal mental 
health diagnoses were not explored further. Finally, this study found that a quarter of acute 
psychiatric patients were admitted for addiction reasons. Objective 2 will examine addiction 
reason for addiction (RFA) in greater depth. 
 
5.2 Characteristics Associated with Reason for Admission for Addiction  
 To our knowledge, previous literature has not examined factors associated with being 
admitted to acute psychiatry for reasons of addiction. However, prior literature has looked at SU 
at admission in acute psychiatry but it did not examine receipt of addiction care (100). 
Understanding the characteristics of those who were admitted for addiction is an important step 
in exploring factors that might also be related to receipt of addiction care.  
This study found that of those admitted for addiction (N=10944), 90.0% had triggered the 
SUBUSE CAP. However, of those patients without an addiction RFA (N=33572), 35% had 
triggered the SUBUSE CAP. Furthermore, as would be expected, receipt of addictions care was 
more common among patients with an addiction RFA compared to other RFAs. With these 
findings in mind, RFA could have an impactful relationship on the trajectory of care in acute 
psychiatry. The RFA variable in the RAI-MH may provide insights into the clinical opinion of 
who might need addictions care. An addiction RFA represents the health care team recognizing 
patients as having an addiction need requiring support within the hospital. However, of the 
patients with an addiction RFA, 33.4% did not receive addiction care. This suggests that even if 
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the clinical team assigns an addiction RFA, there is a gap in care planning and identification of 
addiction treatment needs at admission into acute psychiatry.  
Our study found that although the characteristics of those with an addiction RFA are 
similar to those that trigger the SUBUSE CAP, not everyone with identified substance and/or 
alcohol use have an addiction RFA. Thus, the clinical team’s assessment at admission may not 
identify all persons with an addiction need (i.e. triggering the SUBUSE CAP). Within the initial 
assessment, the severity of substance and/or alcohol use may be missed or the MI becomes the 
focus of intervention even if SU is identified. When a thorough assessment is completed, the 
SUBUSE CAP should be triggered for patients with current or prior problematic substance 
and/or alcohol use.  
Once identified, several aspects regarding the patient should be determined before 
activating care. These aspects include the patients readiness for change, their social, economic 
and, physical health related to substance and/or alcohol use and, their withdrawal symptoms (45). 
However, even when the SUBUSE CAP is triggered, it is possible that individuals are learning 
about having problematic substance and/or alcohol use for the first time (recall, this is their 
primary admission to acute psychiatry). Therefore, the patients’ view on what they need is 
different than the care the clinical team suggest. Based on the addiction liability distribution, 
patients might have met the threshold for need through mental health care but based on their 
current stage of change, they are not ready to initiate addiction care (47,50,52). Activating 
addiction care through harm reduction, education and referrals can be a method to involve the 
patient in care and start progression towards change.  
This study also found that addiction RFA is a driving factor of receiving addiction care: 
as 66.6% of those that had an addiction RFA received addiction care. This understanding can be 
used to begin assessing what characteristics may be associated with receiving addiction care. 
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Within block 1 demographic variables, we found that males between 25 to 44 years old, with less 
than high school education, who were unemployed, never married, had risk of homelessness, 
lived alone or had residential stability were significantly associated with an addiction RFA. This 
is to be expected as this finding is similar to the general population with problematic substance 
and/or alcohol use (87,90). Within block 2 clinical variables, most patients are self-admitted to 
inpatient care, have insight on their own concern and are capable of providing clinical 
information. For block 3 SU variables, it was expected that all variables would be significant and 
that those with addiction RFA would have similar proportion of type of substances used as those 
who triggered the SUBUSE CAP. Finally, in block 4 behaviour and risk variables, all were 
significant but the ABS. This was not expected as aggressive behaviour is often found in 
psychiatric patients with problematic substance and/or alcohol use (83,101–104). However, this 
can be explained as the ABS is embedded within the RHO, which was significant. The RHO 
accounts for the aggressive behaviour the ABS would identify. 
The demonstrated characteristics for addiction RFA are similar to those we would expect 
to be identified with problematic substance and/or alcohol use. Therefore, addiction RFA is 
another viable way to consider need alongside triggering the SUBUSE CAP and symptom 
assessments. 
Although it is important to consider how addiction RFA influences care trajectory, 
acknowledging that it might only act as a lighthouse in guiding care provision is important. 
Instead, an addiction RFA should be coupled with patient advocation for their own needs and/or 
assessment which identifies a clear need for intervention. By demonstrating that those who have 
identified problematic substance and/or alcohol use and the addiction RFA tells us similar 
information – we can utilize the characteristics found significant with addiction RFA to examine 
predicting addiction care. 
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5.3 Factors Associated with Addiction Care  
 A total of ten important factors were discovered to be predictive of receiving addiction 
care within acute psychiatry. Five factors were predictive for increasing the odds of addiction 
care, three factors were predictive for decreasing the odds of addiction care and two factors were 
predictive for increase or decrease based on their specific category. Interestingly, at least one 
factor was found significant from each block variable set identified in objective 2. The following 
sub-section will discuss these factors in length.   
5.3.1 Factors that Increase Odds of Addiction Care 
 Patients with insight into their own mental health have a greater odds of receiving 
addiction support. The association between patients with this characteristic and addiction care 
receipt can be examined through two avenues. First, patients with insight into their own mental 
health have the ability to self-advocate and convey their symptoms to health care providers (105–
107). Secondly, these individuals have an understanding of their problems and are able to seek 
help. Moreover, patients with insight are more ready for change which is important in creating 
SU behaviour changes.  
Clinical recognition of the need for addictions care was also strongly related to receipt of 
addiction care. An addiction RFA demonstrates this recognition and may be indicative that the 
care team developed a plan of care to match this need.  Although this method allows for a 
prompt transition from admission to treatment, we know that a large group of patients are 
missed, ignored or otherwise not recipients of addiction care. Approximately half of those that 
trigger the SUBUSE CAP do not receive an addiction RFA. Moreover, when examining specific 
variables, we see that about a quarter of those with substance problems identified from CAGE 
and those that use 3 or more substances did not have an addiction RFA. Healthcare teams should 
be aware of this bias moving forward in order to adequately delivery care to all that require it. 
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Moreover, addiction RFA should be coupled with symptom assessments to identify problematic 
substance and/or alcohol needs, especially those that occur concurrently with MI, in order to 
provide successful care. 
 Patients with a CAGE score of 1 or more have significant odds of receiving addiction 
care. The CAGE has been reviewed for reliability and validity in detecting alcohol abuse and 
dependence for patients (48,49,82). While created specifically for troubled alcohol use, the 
CAGE has been modified and applied in identifying substance abuse (48,108). The CAGE 
questionnaire validates to the clinical team that the patients have a need for addiction care or they 
require further investigation which is determined through troubling substance and/or alcohol use.  
The presence of withdrawal symptoms for substances and/or alcohol increases the odds 
of receiving addiction. Depending on the substance, withdrawal symptoms can vary from 
anxiousness, trouble concentrating, irritability, shivering and headaches (109,110). These 
symptoms can appear once the effects of the substance(s) are diminishing and/or once the person 
stops using the substance(s) for a period of time where the body begins to crave the high 
(109,110). Withdrawal symptoms aid the healthcare team in identify an addiction concern and 
act as in indicator of severity allowing for the appropriate support to be activated. Both the 
CAGE questionnaire and withdrawal symptoms are visual and behavioural signs and symptoms 
that describe the current and prior substance use of patients. This information identify a problem 
with substances and/or alcohol and determine a need to activate addiction care.  
Presence of a SUD was the factor that explained the greatest variation within the 
predictive model, specifically after controlling for all other factors the odds of receiving 
addiction care increase for those with a SUD compared to those without. Although a SUD is an 
important indicator for a disease, the symptoms for the disease can be present without a formal 
diagnosis and should be used to assess need (111–113). Moreover, based on the increase in odds, 
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a SUD may be related to bias of high severity and acts similar to an addiction RFA, in which a 
SUD is a direct indicator that the clinical team, and the physician, recognize the severity of the 
problem and the need for addiction care. For those patients without a SUD, health care teams 
should use the SUBUSE CAP to consider those who many benefit from addiction care. The 
overall bias in care limits, misses or delays treatment for patients without a diagnosis resulting in 
poorer SU and potential mental health outcomes. Simply, it would be more efficient to treat the 
problem rather than the label alone. 
5.3.2 Factors that Decrease Odds of Addiction Care 
 Females/other have decreased odds of receiving addiction care within acute psychiatry in 
comparison to male. This finding was expected as literature suggests that males are more likely 
to engage with substance and/or alcohol in a problematic way. However, within this population a 
little less than half are females with problematic use of substance and/or alcohol. In fact, the 
proportion of problematic SU has been found to be similar in both men and females (85,114,115) 
though women are more likely to combat barriers in obtaining treatment (84,85). Additionally, 
men experience more social support when initiating care, whereas females do not have enough 
support from social agencies in their treatment endeavours (116). Moreover, of the females that 
activate substance abuse treatment, fewer admission and overall completion of treatment is found 
(84,85). It is important to monitor and examine why addiction care is not activated for all 
patients regardless of gender. 
 Patients admitted to acute psychiatry involuntarily have a much lower odds of receiving 
addiction support. Of all patients with problematic substance and/or alcohol use, 17.7% were 
admitted involuntarily. Although a small number in comparison to those admitted on their own 
volition, it is important to note why such a population, although having a problem, do not receive 
care. Patients who are involuntarily admitted to acute psychiatry are not ready for change, 
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abstinence and, are not open to seeking care. Since this study assessed patients’ first admission, 
those who were involuntarily admitted could be unaware that they have a problem requiring 
support – as they were brought into acute psychiatry by family/loved ones, police or first-
responders. Furthermore, the problem could be acknowledged by the healthcare team but the 
effectiveness of treatment and the benefits it provides are obstructed by the individual choosing 
not to participant. With that as possibility, not giving the limited recourses to people who are 
unwilling to participate is be a valuable method in recourse conservation. Though, if problematic 
substance and/or alcohol use is identified, activating some form of addiction care such as harm 
reduction, education and follow-up/referral are important supports in starting the care process 
(58,59).  
 Patients with risk of self-harm, identified through the SoS scale, have a decrease in their 
odds of receiving addiction care. The SoS scale is scored based off of six items: history of 
ideation related to self-injury, history of suicide attempt(s), mental health symptoms, cognitive 
performance, family concerns about the patient and, suicide plans. The items used within the SoS 
scale are focused on MI and the consequences of severe symptoms leading to self-harm and 
suicide. This is of key importance to ensure the safety of the patient within psychiatry. While it is 
important to identify self-harm, upwards of 40% of those with substance and/or alcohol use have 
history of suicide (117–119) and suicidal behaviours are highly prevalent in those with 
cooccurring SU and MI (19,26,27,119). Over all, it is necessary to provide stabilization for 
patients with risk of self-harm and supporting their identified problematic substance and/or 
alcohol use. This thesis does not attempt to disentangle the connected nature of SU and its 
contribution to self-harm and suicide, concurrently treating the SU along with suicidal ideations 
can impact both behaviours down-stream and the symptoms currently present. Which is 
concerning that those most at risk for self-harm and problematic substance and/or alcohol are at a 
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decreased odds of receiving addiction care. Given the goal of stabilizing and importance of 
optimal care, future research should examine what barriers are in place from care delivery for 
these patients.    
5.1.3 Factors that can Increase or Decrease Odds of Addiction Care 
Age is a factor associated with an increase or decrease in odds of addiction care based on 
the patients’ age group. Patients between the age of 25 to 44 and 45 to 64 have a higher odds of 
receiving addiction care. This trend is to be expected as those with problematic substance and/or 
alcohol use are often between 24 to 44 and 45 to 64 (87,90,120). Additionally, the age 
breakdown found in prior literature is what our study found as well. However, our study found 
that patients 65 and over have a lower odds of receiving addiction care. As we know, this group 
has the smallest prevalence in psychiatry. Moreover, older adults are commonly not identified 
with problematic substance and/or alcohol use as their SU behaviours are not often assessed 
(86,87,90,120). From a treatment perspective, identifying problematic substance and/or alcohol 
use, regardless of age, is imperative in providing care to all patients. 
The patients using three or more substances in the last 90 days have an increased odds of 
receiving addiction care. Further, those who did not use any substances in the last 90 days have a 
decreased odds of the same outcome. Patients using more than one substance, otherwise known 
as polysubstance use, are common in both the general population and within clinical psychiatry 
(121,122). Various adverse drug interactions are possible for those with polysubstance use, 
which can amplify the level of severity of MI (121,122). Future studies should look at the types 
of substances used in patients with polysubstance use and examine if receipt of addiction care 
changes accordingly. While the polysubstance use trend is intuitive in increasing the chances of 
addiction care, it is important to note the decrease based on no substances used. Although this 
group is not currently using substance and/or alcohol, they have triggered the SUBUSE CAP for 
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problematic use. Most likely, this SUBUSE CAP is triggered for prior problematic use of 
substance and/or alcohol within the last 90 days. Without intervention for those who trigger for 
prior use, there is increased odds for future relapse. Patients admitted to acute care are usually at 
their most vulnerable, with severe MI and SU symptoms. In this group, the potential for relapse 
is highest as individuals who have MI might revert to using substances and/or alcohol to self-
medicate or experience worsening of psychiatric symptoms (26,42,43). As the cyclical nature of 
MI and SU is well established, it is incredibly important that an integrated care approach be 
utilized, even for those with prior problematic use especially when they have triggered the 
SUBUSE CAP. Those with severe MI should have their substance and/or alcohol use assessed in 
order to maintain abstinence and provide mental health care that is effective.  
5.1.4 Sensitivity analysis  
The sensitivity analysis provided a more stringent definition of addiction care by 
removing those who used tobacco and, possibly eliminating the delivery of smoking cessation. 
With this change addiction care included contact with an addiction counsellor and/or the focus of 
intervention involving alcohol/dependency treatment. The results show agreement between the 
final model and sensitivity analysis, with slight variation in the OR of variables. As tobacco use 
is identified in majority of patients in acute psychiatry, the removal of these patients will result in 
a reduced number of overall substances used and the relationship between dependent variables 
and use of substance and/or alcohol can be examined without tobacco use. These reasons could 
provide an explanation as to why variables that directly related to use of substances and/or 
alcohol (addiction RFA, withdrawal symptoms, CAGE and SUD) have an increase in their OR. 
Similarly, the use of 3 or more substance is statistically insignificant whereas no substances 
remains significant. Largely, the sensitivity analysis was able to disentangle the focus of 
intervention to include only alcohol/dependency without the smoking cessation component.  
 59 
5.4 Future Research 
Future studies leading from the findings of this thesis should consider creating a severity 
intensity scale which accurately examines the resources utilized by the patient to determine their 
level of severity. This scale can follow similar methodology to Stewart et., al (2019), in which 
the interRAI Child and Youth Mental Health (ChYMH) and Child and Youth Mental Health and 
Developmental Disability (ChYMH-DD) assessment instruments were used to create resource 
intensity scale. This scale would then be used to predict patients who have the most complex 
service needs. A version of this within RAI-MH would be extremely useful in clinical practice – 
especially when understanding who requires addiction support (123).  
A key aspect of this study was to understand factors associated with addiction care 
receipt. It was briefly mentioned within the discussion that number of resources and receipt of 
care can differ depending on the geographic location of the facility within the province of 
Ontario. A small analysis was completed and found that the number of acute psychiatric facilities 
in Ontario that provide addiction care differ (see Appendix C). Thus, subsequent studies should 
use OHMRS data to examine the various facilities across the province of Ontario and their 
potential effect on the receipt of addiction care.  
Future studies should consider the RFA variable, from the OHMRS data, to continue 
investigating addiction care trajectories. As found in this study, addiction RFA has an influence 
of receipt of addiction care. It would be interesting to examine how receipt of addiction care 
differ for those with an addiction RFA versus an addiction RFA combined with another of the 
seven RFA types. Finally, a gender based analysis should be conducted in future studies, as 
within acute inpatient psychiatry approximately 50% were female/other although, males have an 
increased odds of receiving addiction care.  
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5.5 Policy Implications 
 This research provides an in-depth examination of the problematic substance and/or 
alcohol use for patients in acute psychiatry. The overall characteristics of those with problematic 
substance and/or alcohol use and those that receive addiction care are established. As a result of 
these findings and previous literature identifying the importance of addiction care within a 
psychiatric population, future policy recommendations can be made.  
Primarily, it was found that those that receive addiction care are patients who have an 
addiction RFA and/or have a SUD. Although it is crucial these patients receive care, the patients 
who have problematic substance and/or alcohol symptoms identified through the SUBUSE CAP 
are exempt. Expanding the definition of CD and coexisting SU and MI in identifying need can 
improve the receipt of addiction care. In literature, CD is strictly defined as those with diagnosed 
SU and MI but we find that those in acute psychiatry have similar characteristics and symptoms 
profiles yet do not always have a diagnosis. With an understanding that a diagnosis is a label in 
identifying one aspect of a patient, advocating for a more fluid definition of need can mitigate 
the bias. Instead, utilizing more symptom and clinical profiles for identifying need is a way to 
more broadly provide care. Using the SUBUSE CAP is a method in recognizing a need, allowing 
for further investigation to determine the level of severity and adequality match to the correct 
support.  
A seminal finding from this study was the lack of integrated care applied when SU and 
MI were present within psychiatric patients. Evidence suggests that targeting SU and MI 
simultaneously and, within the same environment is a key feature in providing high-quality care. 
By providing addiction care to those with both illnesses can mitigate relapse or reliance on 
substances and/or alcohol, reduce the severity of symptoms related to MI and, create a seamless 
care environment (60,61,81). It is crucial for best-practice guidelines and facilities to adopt an 
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integrated care approach and advance the discussion of collaborative SU and MI care within 
clinical practice, whether within inpatient or outpatient psychiatry.  
In British Columbia, Canada, the ministry of health released a literature review and guide 
document, highlighting potential avenues for applying the integrated care model into SU and MI 
supports within the community (124). Three approaches to how this could be achieved are: (i) 
communication model, (ii) co-location and collaborative model and (iii) integrated team model 
(124,125). The communication model employs referral and information sharing methods across 
mental health and addiction providers in the province to improve sharing of information and 
enhance the movement from one location to another. Although this model would assist in 
creating referrals and improve the information sharing process, patients may not want to engage 
with multiple care providers in various location. Multiple locations and various days of different 
care delivery increase the chances of patients dropping out (60,124,125). The collaborative 
model suggests that the care providers work together in proximity to each other. In this version, 
health care providers are in the same facility (“one-stop shop” concept). Although, proximity 
does not always guarantee that care receipt will be provided without the appropriate assessment 
identifying a need for care (124,125). Interestingly, literature on this model suggests that it is 
only beneficial for low severity patients in the community. However, Kates et. al (2011) found 
the collaborative approach in a primary care setting within Hamilton, Ontario to be valuable in 
supporting their patients with onsite care for MI and SU, that led to positive outcomes (126). 
There is potential that a collaborative model is not as effective in a community setting as it 
within a primary care setting.  
The final version is the integrated team model, which builds a collaborative SU and MI 
facility in areas where severity of illnesses are highest (i.e. targeting those most at risk - 
homeless population or where traditional services are unlikely to reach). This model would be 
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the most holistic approach which aims to address all social determinants of health by providing 
not only SU and MI care but food, shelter, clothing, occupational therapy, rehabilitation, 
employment and income support etc. The ultimate goal of an integrated team model is to target 
the most severe cases and provide care through one accountable organization overseeing the 
process (127).  
In reviewing all versions of the integrated care approach - the collaborative model if 
applied to an acute psychiatric facility could be the most beneficial. A large concern with the 
collaborative model was that only those with low severity would approach this form of care 
within the community as they are capable of self-management and care activation. This concern 
would not be as relevant in acute psychiatry as those with the most severe cases have activated 
care to meet their multitude of complexities. If a collaborative approach to integrated care is used 
within acute psychiatry, the patients can be in one location where they receive both addiction and 
psychiatric support without needing to engage with various facilities in numerous locations. 
Moreover, once the severity of symptoms are reduced within acute psychiatry referrals can be 
made at discharge to collaborative community care, where support would continue with 
symptoms management and impulse control.  
 
5.6 Limitation 
Although this thesis has many strengths which allow for meaningful findings, various 
limitations are identified. When applying an integrated care lens, this study only examined the 
receipt of formal addiction care and not care specifically for MI. However, it is understood 
through literature that MI is a priority focus of psychiatric care and where care is often activated. 
This study uses an acute care population which cannot be directly linked to the general 
population. Acute care is an important study sample as it often provides the worst case scenarios 
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or most severe symptoms allowing for examination of care during difficult times. Additionally, 
delivery of care in the community and other health settings are necessary in reducing the burden 
on the hospital settings. In situations where the hospital is unable to meet the patients’ addiction 
needs due to staff or recourse restriction than referrals to other settings are an option. Reports of 
referrals to community addiction/concurrent disorder settings were not examined within this 
study. It would be meaningful to see who received referrals into the community (i.e. (i) those that 
received addiction care or those that did not and, (ii) what type of characteristics, factors etc. 
were associated with referrals).  
We were unable to assess readmissions and follow-ups for patients in this study. It would 
have been useful to examine if patients are readmitted, how long after their first discharge and 
why they were readmitted (i.e. RFA) in creating a larger more comprehensive image of the 
healthcare process. Moreover, while the RAI-MH is a comprehensive assessment that gathers an 
immense amount of information, we are only assessing this information retrospectively. This 
study is unable to ask follow up or clarifying questions.  
Moreover, some items within the assessment are subject to inherent inaccuracy. If a 
health care provider has addictions training and treats a patient – the assessor will code for that 
health care provider instead of an addiction counsellor. This section of code includes six other 
health care providers besides addiction counsellor which could provide addiction care. For 
example, if a patient is visited by a social worker who treats them for substance use concerns, the 
data will only recognize a social worker during that visit. This thesis used the focus of 
intervention alcohol/drug treatment/smoking cessation variable to assist in accounting for all 
addiction care, not just addiction counsellor visits. Unfortunately, the focus of intervention for 
alcohol/drug treatment/smoking cessation does not allow for disentanglement between the three 
components of care. In future editions of the RAI-MH, modifying focus of intervention into 
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alcohol/drug treatment and smoking cessation separately would be beneficial. To best deal with 
this issue, this study conducted a sensitivity analysis by removing patients that used tobacco to 
control for smoking cessation (under the assumption that those that do not smoke will not get 
smoking cessation measures). 
The association between ethnicity and receipt of addiction care was not assessed as race 
or ethnicity is not routinely included in the OMHRS data. To measure racial and ethnic 
inequalities in future research, CIHI has created an interim race standard to ensure that high-
quality data is collected and analyzed while maintaining cultural safety and ongoing dialogue 
with communities. Within this standard, race is described as the social construct to categorize 
people (i.e. skin color) and ethnicity is an association to a cultural group (i.e. religious affiliation, 
migration history, cultural traditions, nationality) (128). Moreover, First Nations, Inuit and Métis 
have ownership over collection and use of their own data under the OCAP standards (129). 
Therefore, Indigenous groups warrant consideration and are included in their own group 
independent from the racial group questions (128). This distinction is designed to allow 
Indigenous people to self-identify (128). Future research should consider the role of race and 
ethnicity on receipt of care as individuals in certain minority groups are less represented in 
treatment settings and have lower rates of treatment completion (130–132). Moving forward, 
research should investigate patterns of substance use among ethnic groups and, how ethnicity 
affects receipt of addiction care.  
 
6.0 Conclusion 
The availability and use of standardized assessment data within Ontario creates the 
opportunity to capture the proportion of patients with potential problematic substance and/or 
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alcohol use at first admission to inpatient psychiatry in Ontario, Canada. In looking at this data, 
about half have an addiction need but only a quarter actually receive addiction care.   
A substance use diagnosis was a strong factor associated with receipt of addiction care. 
Interestingly, the results also demonstrate a number of factors that can be used to identify need 
for addictions care, regardless of diagnosis, including withdrawal symptoms and the CAGE 
questionnaire. Utilizing a less diagnostic tool will assist in capturing a wider cohort of patients 
who will benefit from specific support. This study also found that the SUBUSE CAP is an 
adequate tool in identifying those with substance and/or alcohol need and should continue to be 
used in clinical practice.  
Although it is well recognized that MI and SU occur simultaneously, this study 
demonstrates that within acute psychiatry self-harm and suicidal behaviours in patients reduces 
the odds receiving addiction support. This finding is somewhat concerning as it indicates those 
with severe mental health circumstances and who use substances may not be offered addictions 
care. Thus, this study provides some insight and evidence into acute psychiatric care and 
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Appendix A: Reference groups 
 
Appendix A Table 1 Reference group used for logistic regression analyses 
Variables Reference Group 
Block 1  
Age 18-24 
Gender Female 
Education Less than high school or unknown 
Employment Employed 
Unemployment Risk Risk 
Marital Status Never married 
Homelessness Yes 
Lived Alone  Yes 
Residential Stability Yes 
Block 2  
Length of Stay 3-7 days 
Insight into own Mental Health Yes 
Involuntary Admission Yes 
Incompetent to disclose information related to 
clinical records 
Yes 
Reason for Admission Addiction Yes 
Block 3 
 
Alcohol Use Yes 
Tobacco Use Yes 
Inhalant Use Yes 
Hallucinogen Use Yes 
Crack/Cocaine Use Yes 
Stimulant Use Yes 
Opiate Use  Yes 
Cannabis Use Yes 
Gambling Yes 
Medication Misuse Yes 
Withdrawal Symptoms Yes 
CAGE  
Potential problem with substance 
addiction 
Substance Use Scale 1-2 substance(s) 
Block 4  
Harm to Others (RHO) Score of 1 or more 
Self-Care Index (SCI) Score of 1 or more 
 82 
Variables Reference Group 
Severity of Self-harm (SoS) Score of 1 or more 
ADL Scale Yes 
IADL Scale Yes 
Block 5  
Depressive Symptom Index (DSI) Score of 3 or more 
Anhedonia Yes 
Positive Symptom Scale (PSS) Score of 3 or more 
Trauma CAP Triggered 
Substance Use Disorder Diagnosis Yes 
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Appendix B: Combined Model Tables 
Appendix B Table 1 Multivariate logistic regression combined model 1 examining the 
relationship between demographic, clinical, substance use, behaviour and risk and, mental status 
characteristics by receipt of addiction care 
Variables Combined Model 1 
OR (95% CI) p-value 
Block 1   
Age 25-44 1.16 (1.07-1.26) 0.0005 
45-64 1.07 (0.98-1.17) 0.14 
65+ 0.94 (0.79-1.10) 0.42 
Gender 0.88 (0.82-0.94) 0.0002 
Education Highschool 1.05 (0.96-1.16) 0.27 
> Highschool 1.00 (0.92-1.09) 0.98 
Employment 0.96 (0.89-1.03) 0.23 
Unemployment Risk 1.06 (0.99-1.09) 0.12 
Homelessness 0.86 (0.80-0.93) <.0001 
Block 2   
Insight into own Mental Health 1.20 (1.08-1.33) 0.0006 
Involuntary Admission 0.68 (0.63-0.74) <.0001 
Incompetent to disclose information related to clinical records 
0.74 (0.56-0.96) 0.03 
Reason for Admission Addiction 2.05 (1.91-2.20) <.0001 
Block 3   
Alcohol Use 1.22 (1.12-1.32) <.0001 
Tobacco Use 1.59 (1.47-1.71) <.0001 
Inhalant Use 0.62 (0.45-0.85) 0.003 
Crack/Cocaine Use 1.24 (1.12-1.38) <.0001 
Stimulant Use 1.11 (0.97-1.28) 0.13 
Opiate Use  1.51 (1.34-1.70) <.0001 
Medication Misuse 0.88 (0.81-0.96) 0.003 
Withdrawal Symptoms 1.87 (1.34-1.70) <.0001 
CAGE 2.08 (1.94-2.24) <.0001 
Substance Use Scale No Substances 0.78 (0.66-0.91) 0.002 
3+ Substances 1.06 (0.96-1.18) 0.27 
Block 4   
Harm to Others (RHO) 1.01 (0.94-1.08) 0.87 
Self-Care Index (SCI) 0.88 (0.81-0.95) 0.001 
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Variables Combined Model 1 
OR (95% CI) p-value 
Severity of Self-harm (SoS) 0.73 (0.67-0.79) <.0001 
IADL Scale 0.92 (0.84-0.99) 0.03 
Block 5   
Positive Symptom Scale (PSS) 0.96 (0.89-1.05) 0.38 
Trauma CAP 1.08 (1.00-1.18) 0.07 
Substance Use Disorder Diagnosis 2.81 (2.62-3.00) <.0001 
C-statistic 0.820 




Appendix B Table 2 Multivariate logistic regression combined model 2 examining the 
relationship between demographic, clinical, substance use, behaviour and risk and, mental status 
characteristics by receipt of addiction care 
Variables Combined Model 2 
OR (95% CI) p-value 
Block 1   
Age 25-44 1.16 (1.07-1.26) 0.0004 
45-64 1.07 (0.98-1.18) 0.12 
65+ 0.94 (0.79-1.10) 0.42 
Gender 0.89 (0.83-0.95) 0.0005 
Education Highschool 1.05 (0.96-1.16) 0.3 
> Highschool 1.00 (0.92-1.09) 0.96 
Employment 0.96 (0.89-1.03) 0.23 
Unemployment Risk 1.06 (0.99-1.09) 0.1 
Homelessness 0.86 (0.79-0.92) <.0001 
Block 2   
Insight into own Mental Health 1.22 (1.10-1.35) 0.0002 
Involuntary Admission 0.68 (0.63-0.74) <.0001 
Incompetent to disclose information related to clinical records 0.74 (0.56-0.96) 0.03 
Reason for Admission Addiction 2.05 (1.91-2.20) <.0001 
Block 3   
Alcohol Use 1.22 (1.12-1.32) <.0001 
Tobacco Use 1.59 (1.48-1.72) <.0001 
Inhalant Use 0.62 (0.45-0.85) 0.003 
Crack/Cocaine Use 1.24 (1.12-1.38) <.0001 
Stimulant Use 1.11 (0.97-1.28) 0.14 
Opiate Use  1.51 (1.34-1.70) <.0001 
Medication Misuse 0.88 (0.81-0.96) 0.004 
Withdrawal Symptoms 1.87 (1.70-2.04) <.0001 
CAGE 2.08 (1.95-2.25) <.0001 
Substance Use Scale No Substances 0.78 (0.66-0.92) 0.002 
3+ Substances 1.06 (0.96-1.18) 0.27 
Block 4   
Harm to Others (RHO) 1.00 (0.94-1.08) 0.85 
Self-Care Index (SCI) 0.87 (0.81-0.93) 0.001 
Severity of Self-harm (SoS) 0.73 (0.67-0.79) <.0001 
IADL Scale 0.91 (0.84-0.99) 0.03 
Block 5   
Substance Use Disorder Diagnosis 2.80 (2.62-3.00) <.0001 
C-statistic 0.820 
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Appendix B Table 3 Multivariate logistic regression combined model 3 examining the 
relationship between demographic, clinical, substance use, behaviour and risk and, mental status 
characteristics by receipt of addiction care 
Variables Combined Model 3 
OR (95% CI) p-value 
Block 1   
Age 25-44 1.16 (1.07-1.26) 0.0003 
45-64 1.07 (0.98-1.17) 0.13 
65+ 0.91 (0.77-1.07) 0.24 
Gender 0.90 (0.84-0.96) 0.001 
Education Highschool 1.05 (0.96-1.16) 0.29 
> Highschool 1.00 (0.92-1.09) 0.98 
Employment 0.97 (0.90-1.04) 0.38 
Unemployment Risk 1.06 (0.98-1.14) 0.14 
Homelessness 0.86 (0.79-0.92) <.0001 
Block 2   
Insight into own Mental Health 1.32 (1.18-1.44) <.0001 
Involuntary Admission 0.67 (0.62-0.73) <.0001 
Incompetent to disclose information related to clinical records 0.73 (0.58-0.95) 0.02 
Reason for Admission Addiction 2.06 (1.93-2.21) <.0001 
Block 3   
Alcohol Use 1.24 (1.14-1.34) <.0001 
Tobacco Use 1.59 (1.48-1.72) <.0001 
Inhalant Use 0.63 (0.45-0.87) 0.004 
Crack/Cocaine Use 1.25 (1.12-1.39) <.0001 
Stimulant Use 1.10 (0.96-1.26) 0.17 
Opiate Use  1.53 (1.34-1.72) <.0001 
Medication Misuse 0.89 (0.82-0.97) 0.008 
Withdrawal Symptoms 1.86 (1.70-2.03) <.0001 
CAGE 2.09 (1.95-2.25) <.0001 
Substance Use Scale No Substances 0.79 (0.67-0.93) 0.0035 
3+ Substances 1.06 (0.95-1.18) 0.3 
Block 4   
Severity of Self-harm (SoS) 0.70 (0.65-0.76) <.0001 
Block 5   
Substance Use Disorder Diagnosis 2.81 (2.62-3.01) <.0001 
C-statistic 0.819 
*Coloured cell = Variable is non-significant and will be removed from subsequent model 
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Appendix B Table 4 Multivariate logistic regression combined model 4 examining the 
relationship between demographic, clinical, substance use, behaviour and risk and, mental status 
characteristics by receipt of addiction care 
Variables Combined Model 4 
OR (95% CI) p-value 
Block 1   
Age 25-44 1.24 (1.1401.34) <.0001 
45-64 1.13 (1.04-1.24) 0.006 
65+ 0.88 (0.75-1.03) 0.11 
Gender 0.88 (0.82-9.94) <.0001 
Education Highschool 1.03 (0.94-1.13) 0.54 
> Highschool 0.96 (0.89-1.02) 0.3 
Employment 0.95 (0.89-1.02) 0.18 
Unemployment Risk 1.05 (0.98-1.13) 0.19 
Homelessness 0.89 (0.82-0.94) 0.001 
Block 2   
Insight into own Mental Health 1.32 (1.19-1.45) <.0001 
Involuntary Admission 0.67 (0.61-0.73) <.0001 
Incompetent to disclose information related to clinical records 0.71 (0.55-0.93) 0.01 
Reason for Admission Addiction 2.13 (2.00-2.28) <.0001 
Block 3   
Withdrawal Symptoms 1.95 (1.79-2.13) <.0001 
CAGE 2.24 (2.09-2.40) <.0001 
Substance Use Scale No Substances 0.59 (0.51-0.69) <.0001 
3+ Substances 1.52 (1.41-1.64) <.0001 
Block 4   
Severity of Self-harm (SoS) 0.68 (0.63-0.74) <.0001 
Block 5   
Substance Use Disorder Diagnosis 2.97 (2.7703.18) <.0001 
C-statistic 0.814 




Appendix B Table 5 Multivariate logistic regression combined model 5 examining the 
relationship between demographic, clinical, substance use, behaviour and risk and, mental status 
characteristics by receipt of addiction care 
Variables Combined Model 5 
OR (95% CI) p-value 
Block 1   
Age 25-44 1.24 (1.14-1.34) <.0001 
45-64 1.13 (1.04-1.24) 0.006 
65+ 0.87 (0.75-1.02) 0.09 
Gender 0.88 (0.82-0.94) <.0001 
Education Highschool 1.03 (0.94-1.13) 0.52 
> Highschool 0.96 (0.88-1.04) 0.31 
Employment 0.95 (0.89-1.02) 0.18 
Unemployment Risk 1.05 (0.98-1.13) 0.19 
Homelessness 0.89 (0.92-0.95) 0.001 
Block 2   
Insight into own Mental Health 1.23 (1.20-1.46) <.0001 
Involuntary Admission 0.66 (0.61-0.72) <.0001 
Incompetent to disclose information related to clinical records   
Reason for Admission Addiction 2.12 (1.98-2.27) <.0001 
Block 3   
Withdrawal Symptoms 1.95 (1.79-2.13) <.0001 
CAGE 2.24 (2.09-2.40) <.0001 
Substance Use Scale No Substances 0.59 (0.51-0.69) <.0001 
3+ Substances 1.52 (1.41-1.64) <.0001 
Block 4   
Severity of Self-harm (SoS) 0.68 (0.63-0.74) <.0001 
IADL Scale   
Block 5   
Substance Use Disorder Diagnosis 2.97 (2.78-3.18) <.0001 
C-statistic 0.814 




Appendix C: Addiction care provision based on facility health region 
Appendix C Table 1 Number of addiction care visits from 2006 to 2018 by Ontario region 
Region  Number of Addiction Care Visits 
Erie St. Clair 1429 
South West 2267 
Waterloo Wellington 990 
Hamilton Niagara Haldimand Brant  2039 
Central West 894 
Mississauga Halton 889 
Toronto Central 3674 
Central 1572 
Central East 1860 
South East 956 
Champlain 1986 
North Simcoe Muskoka 1202 
North East 1593 
North West 613 
 
 
 
